JP2009525978A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009525978A5 JP2009525978A5 JP2008553429A JP2008553429A JP2009525978A5 JP 2009525978 A5 JP2009525978 A5 JP 2009525978A5 JP 2008553429 A JP2008553429 A JP 2008553429A JP 2008553429 A JP2008553429 A JP 2008553429A JP 2009525978 A5 JP2009525978 A5 JP 2009525978A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- ylamino
- pyrimidin
- phenyl
- trifluoromethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 halo substituted Chemical class 0.000 claims description 52
- 229910052739 hydrogen Inorganic materials 0.000 claims description 18
- 239000001257 hydrogen Substances 0.000 claims description 18
- 125000000217 alkyl group Chemical group 0.000 claims description 13
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 13
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 12
- 150000001875 compounds Chemical class 0.000 claims description 9
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 6
- 125000001475 halogen functional group Chemical group 0.000 claims description 6
- 150000002431 hydrogen Chemical class 0.000 claims description 5
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims description 4
- 125000001072 heteroaryl group Chemical group 0.000 claims description 4
- 125000005349 heteroarylcycloalkyl group Chemical group 0.000 claims description 4
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 4
- 125000000842 isoxazolyl group Chemical group 0.000 claims description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 4
- 125000003226 pyrazolyl group Chemical group 0.000 claims description 4
- 125000004076 pyridyl group Chemical group 0.000 claims description 4
- 125000000335 thiazolyl group Chemical group 0.000 claims description 4
- 125000001544 thienyl group Chemical group 0.000 claims description 4
- MRYASQNSJAHEQV-UHFFFAOYSA-N 1$l^{2}-azolidin-2-one Chemical group O=C1CCC[N]1 MRYASQNSJAHEQV-UHFFFAOYSA-N 0.000 claims description 3
- 125000004520 1,3,4-thiadiazolyl group Chemical group 0.000 claims description 3
- 125000006652 (C3-C12) cycloalkyl group Chemical group 0.000 claims description 2
- CHXUFRRQOZZSNV-UHFFFAOYSA-N 1-methylpiperidine Chemical group [CH2]N1CCCCC1 CHXUFRRQOZZSNV-UHFFFAOYSA-N 0.000 claims description 2
- 108020005497 Nuclear hormone receptors Proteins 0.000 claims description 2
- 125000002947 alkylene group Chemical group 0.000 claims description 2
- 125000005418 aryl aryl group Chemical group 0.000 claims description 2
- 125000004350 aryl cycloalkyl group Chemical group 0.000 claims description 2
- 125000006448 cycloalkyl cycloalkyl group Chemical group 0.000 claims description 2
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 125000006203 morpholinoethyl group Chemical group [H]C([H])(*)C([H])([H])N1C([H])([H])C([H])([H])OC([H])([H])C1([H])[H] 0.000 claims description 2
- 125000001064 morpholinomethyl group Chemical group [H]C([H])(*)N1C([H])([H])C([H])([H])OC([H])([H])C1([H])[H] 0.000 claims description 2
- 101700068080 nhr-11 Proteins 0.000 claims description 2
- 125000003386 piperidinyl group Chemical group 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 239000011780 sodium chloride Substances 0.000 claims description 2
- 239000012453 solvate Substances 0.000 claims description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 2
- 102000030951 Phosphotransferases Human genes 0.000 claims 3
- 108091000081 Phosphotransferases Proteins 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 3
- WEYVUXBHEGESFJ-UHFFFAOYSA-N 5-tert-butyl-2-methyl-N-[4-methyl-3-[[5-[6-(2-morpholin-4-ylethylamino)pyrimidin-4-yl]pyrimidin-4-yl]amino]phenyl]pyrazole-3-carboxamide Chemical compound C1=C(NC=2C(=CN=CN=2)C=2N=CN=C(NCCN3CCOCC3)C=2)C(C)=CC=C1NC(=O)C1=CC(C(C)(C)C)=NN1C WEYVUXBHEGESFJ-UHFFFAOYSA-N 0.000 claims 2
- 102100006440 CSK Human genes 0.000 claims 2
- 108060006697 CSK Proteins 0.000 claims 2
- 102000027766 FGFR3 Human genes 0.000 claims 2
- 102100019516 JAK2 Human genes 0.000 claims 2
- 101700016050 JAK2 Proteins 0.000 claims 2
- 102100013180 KDR Human genes 0.000 claims 2
- 101700033678 KDR Proteins 0.000 claims 2
- 101710030888 KDR Proteins 0.000 claims 2
- 101700033896 LCK Proteins 0.000 claims 2
- TWKNFHDNZFAITE-UHFFFAOYSA-N N-[3-[[3-(6-aminopyrimidin-4-yl)pyridin-2-yl]amino]-4-methylphenyl]-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide Chemical compound C1=NC(C)=CN1C1=CC(C(=O)NC=2C=C(NC=3C(=CC=CN=3)C=3N=CN=C(N)C=3)C(C)=CC=2)=CC(C(F)(F)F)=C1 TWKNFHDNZFAITE-UHFFFAOYSA-N 0.000 claims 2
- XVTSSUFTQNPMRW-UHFFFAOYSA-N N-[3-[[5-[6-(cyclopropylamino)pyrimidin-4-yl]pyrimidin-4-yl]amino]-4-methylphenyl]-3-(trifluoromethyl)benzamide Chemical compound C1=C(NC=2C(=CN=CN=2)C=2N=CN=C(NC3CC3)C=2)C(C)=CC=C1NC(=O)C1=CC=CC(C(F)(F)F)=C1 XVTSSUFTQNPMRW-UHFFFAOYSA-N 0.000 claims 2
- IMTYSVRRURCPFH-UHFFFAOYSA-N N-[4-methyl-3-[[3-[6-(2-morpholin-4-ylethylamino)pyrimidin-4-yl]pyridin-2-yl]amino]phenyl]-3-(trifluoromethyl)benzamide Chemical compound C1=C(NC=2C(=CC=CN=2)C=2N=CN=C(NCCN3CCOCC3)C=2)C(C)=CC=C1NC(=O)C1=CC=CC(C(F)(F)F)=C1 IMTYSVRRURCPFH-UHFFFAOYSA-N 0.000 claims 2
- 108060005033 NTRK2 Proteins 0.000 claims 2
- 102100007893 PRKCA Human genes 0.000 claims 2
- 101710038828 PRKCA Proteins 0.000 claims 2
- 101710037124 TEK Proteins 0.000 claims 2
- 108010081267 Type 3 Fibroblast Growth Factor Receptor Proteins 0.000 claims 2
- 150000001408 amides Chemical class 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 230000002401 inhibitory effect Effects 0.000 claims 2
- BBSQUJNFEBKAAZ-UHFFFAOYSA-N 1-tert-butyl-5-methyl-N-[4-methyl-3-[[3-[6-(2-morpholin-4-ylethylamino)pyrimidin-4-yl]pyridin-2-yl]amino]phenyl]pyrazole-3-carboxamide Chemical compound CC(C)(C)N1C(C)=CC(C(=O)NC=2C=C(NC=3C(=CC=CN=3)C=3N=CN=C(NCCN4CCOCC4)C=3)C(C)=CC=2)=N1 BBSQUJNFEBKAAZ-UHFFFAOYSA-N 0.000 claims 1
- FCFGJNOOQYQMKY-UHFFFAOYSA-N 1-tert-butyl-5-methylpyrazole-3-carboxylic acid Chemical compound CC1=CC(C(O)=O)=NN1C(C)(C)C FCFGJNOOQYQMKY-UHFFFAOYSA-N 0.000 claims 1
- VQBZPCCITUCADP-UHFFFAOYSA-N 1-tert-butyl-N-[3-[[3-[6-(cyclopropylamino)pyrimidin-4-yl]pyridin-2-yl]amino]-4-methylphenyl]-5-methylpyrazole-3-carboxamide Chemical compound CC(C)(C)N1C(C)=CC(C(=O)NC=2C=C(NC=3C(=CC=CN=3)C=3N=CN=C(NC4CC4)C=3)C(C)=CC=2)=N1 VQBZPCCITUCADP-UHFFFAOYSA-N 0.000 claims 1
- MERFFENWYUCYNE-UHFFFAOYSA-N 3-(4-methylimidazol-1-yl)-N-[4-methyl-3-[[3-[6-(2-morpholin-4-ylethylamino)pyrimidin-4-yl]pyridin-2-yl]amino]phenyl]-5-(trifluoromethyl)benzamide Chemical compound C1=NC(C)=CN1C1=CC(C(=O)NC=2C=C(NC=3C(=CC=CN=3)C=3N=CN=C(NCCN4CCOCC4)C=3)C(C)=CC=2)=CC(C(F)(F)F)=C1 MERFFENWYUCYNE-UHFFFAOYSA-N 0.000 claims 1
- RKYVSMAQCHXLNL-UHFFFAOYSA-N 3-[[3-(6-acetamidopyrimidin-4-yl)pyridin-2-yl]amino]-N-[4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-4-methylbenzamide Chemical compound C1CN(CC)CCN1CC(C(=C1)C(F)(F)F)=CC=C1NC(=O)C1=CC=C(C)C(NC=2C(=CC=CN=2)C=2N=CN=C(NC(C)=O)C=2)=C1 RKYVSMAQCHXLNL-UHFFFAOYSA-N 0.000 claims 1
- YIXNVUGSUJKVGI-UHFFFAOYSA-N 3-[[3-(6-aminopyrimidin-4-yl)pyridin-2-yl]amino]-4-methyl-N-[3-(trifluoromethyl)phenyl]benzamide Chemical compound CC1=CC=C(C(=O)NC=2C=C(C=CC=2)C(F)(F)F)C=C1NC1=NC=CC=C1C1=CC(N)=NC=N1 YIXNVUGSUJKVGI-UHFFFAOYSA-N 0.000 claims 1
- XBJPQNVXIKPVDG-UHFFFAOYSA-N 3-[[3-(6-aminopyrimidin-4-yl)pyridin-2-yl]amino]-N-[4-chloro-3-(trifluoromethyl)phenyl]-4-methylbenzamide Chemical compound CC1=CC=C(C(=O)NC=2C=C(C(Cl)=CC=2)C(F)(F)F)C=C1NC1=NC=CC=C1C1=CC(N)=NC=N1 XBJPQNVXIKPVDG-UHFFFAOYSA-N 0.000 claims 1
- HQHRVDFUCYZFFO-UHFFFAOYSA-N 3-[[3-[6-(cyclopropylamino)pyrimidin-4-yl]pyridin-2-yl]amino]-4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]benzamide Chemical compound C1=NC(C)=CN1C1=CC(NC(=O)C=2C=C(NC=3C(=CC=CN=3)C=3N=CN=C(NC4CC4)C=3)C(C)=CC=2)=CC(C(F)(F)F)=C1 HQHRVDFUCYZFFO-UHFFFAOYSA-N 0.000 claims 1
- PMIUZAHUKBNZOD-UHFFFAOYSA-N 3-[[3-[6-(cyclopropylamino)pyrimidin-4-yl]pyridin-2-yl]amino]-4-methyl-N-[3-(trifluoromethyl)phenyl]benzamide Chemical compound CC1=CC=C(C(=O)NC=2C=C(C=CC=2)C(F)(F)F)C=C1NC1=NC=CC=C1C(N=CN=1)=CC=1NC1CC1 PMIUZAHUKBNZOD-UHFFFAOYSA-N 0.000 claims 1
- DELUCWCUEQNJET-UHFFFAOYSA-N 3-tert-butyl-N-[4-methyl-3-[[5-[6-(2-morpholin-4-ylethylamino)pyrimidin-4-yl]pyrimidin-4-yl]amino]phenyl]-1,2-oxazole-5-carboxamide Chemical compound C1=C(NC=2C(=CN=CN=2)C=2N=CN=C(NCCN3CCOCC3)C=2)C(C)=CC=C1NC(=O)C1=CC(C(C)(C)C)=NO1 DELUCWCUEQNJET-UHFFFAOYSA-N 0.000 claims 1
- OVCNKJJDRNKWCC-UHFFFAOYSA-N 4-(4-ethylpiperazin-1-yl)-N-[4-methyl-3-[[3-[6-(2-morpholin-4-ylethylamino)pyrimidin-4-yl]pyridin-2-yl]amino]phenyl]-3-(trifluoromethyl)benzamide Chemical compound C1CN(CC)CCN1C1=CC=C(C(=O)NC=2C=C(NC=3C(=CC=CN=3)C=3N=CN=C(NCCN4CCOCC4)C=3)C(C)=CC=2)C=C1C(F)(F)F OVCNKJJDRNKWCC-UHFFFAOYSA-N 0.000 claims 1
- FXMLXWBCXKCEHI-UHFFFAOYSA-N 4-chloro-N-[3-[[3-[6-(cyclopropylamino)pyrimidin-4-yl]pyridin-2-yl]amino]-4-methylphenyl]-3-(trifluoromethyl)benzamide Chemical compound C1=C(NC=2C(=CC=CN=2)C=2N=CN=C(NC3CC3)C=2)C(C)=CC=C1NC(=O)C1=CC=C(Cl)C(C(F)(F)F)=C1 FXMLXWBCXKCEHI-UHFFFAOYSA-N 0.000 claims 1
- HUSDJQJTMXHXMB-UHFFFAOYSA-N 4-chloro-N-[4-methyl-3-[[3-[6-(2-morpholin-4-ylethylamino)pyrimidin-4-yl]pyridin-2-yl]amino]phenyl]-3-(trifluoromethyl)benzamide Chemical compound C1=C(NC=2C(=CC=CN=2)C=2N=CN=C(NCCN3CCOCC3)C=2)C(C)=CC=C1NC(=O)C1=CC=C(Cl)C(C(F)(F)F)=C1 HUSDJQJTMXHXMB-UHFFFAOYSA-N 0.000 claims 1
- YJPIPJQFJFSVPL-UHFFFAOYSA-N 4-methyl-3-[[3-[6-(2-morpholin-4-ylethylamino)pyrimidin-4-yl]pyridin-2-yl]amino]-N-[3-(trifluoromethyl)phenyl]benzamide Chemical compound CC1=CC=C(C(=O)NC=2C=C(C=CC=2)C(F)(F)F)C=C1NC1=NC=CC=C1C(N=CN=1)=CC=1NCCN1CCOCC1 YJPIPJQFJFSVPL-UHFFFAOYSA-N 0.000 claims 1
- IGNMDMQLSZRMEP-UHFFFAOYSA-N 4-methyl-3-[[5-[6-(methylamino)pyrimidin-4-yl]pyrimidin-4-yl]amino]-N-[2-(2-oxoazetidin-1-yl)-5-(trifluoromethyl)phenyl]benzamide Chemical compound C1=NC(NC)=CC(C=2C(=NC=NC=2)NC=2C(=CC=C(C=2)C(=O)NC=2C(=CC=C(C=2)C(F)(F)F)N2C(CC2)=O)C)=N1 IGNMDMQLSZRMEP-UHFFFAOYSA-N 0.000 claims 1
- ZIXHPXFDJRMTEV-UHFFFAOYSA-N 4-methyl-3-[[5-[6-(methylamino)pyrimidin-4-yl]pyrimidin-4-yl]amino]-N-[2-(2-oxopyrrolidin-1-yl)-5-(trifluoromethyl)phenyl]benzamide Chemical compound C1=NC(NC)=CC(C=2C(=NC=NC=2)NC=2C(=CC=C(C=2)C(=O)NC=2C(=CC=C(C=2)C(F)(F)F)N2C(CCC2)=O)C)=N1 ZIXHPXFDJRMTEV-UHFFFAOYSA-N 0.000 claims 1
- XTQBAJPFHCZWRH-UHFFFAOYSA-N 4-methyl-3-[[5-[6-(methylamino)pyrimidin-4-yl]pyrimidin-4-yl]amino]-N-[2-(4-methylpiperazin-1-yl)-5-(trifluoromethyl)phenyl]benzamide Chemical compound C1=NC(NC)=CC(C=2C(=NC=NC=2)NC=2C(=CC=C(C=2)C(=O)NC=2C(=CC=C(C=2)C(F)(F)F)N2CCN(C)CC2)C)=N1 XTQBAJPFHCZWRH-UHFFFAOYSA-N 0.000 claims 1
- GAJZQZBZTMHQMC-UHFFFAOYSA-N 4-methyl-3-[[5-[6-(methylamino)pyrimidin-4-yl]pyrimidin-4-yl]amino]-N-[2-(morpholin-4-ylmethyl)-5-(trifluoromethyl)phenyl]benzamide Chemical compound C1=NC(NC)=CC(C=2C(=NC=NC=2)NC=2C(=CC=C(C=2)C(=O)NC=2C(=CC=C(C=2)C(F)(F)F)CN2CCOCC2)C)=N1 GAJZQZBZTMHQMC-UHFFFAOYSA-N 0.000 claims 1
- YDUJLMHURBVFSI-UHFFFAOYSA-N 4-methyl-3-[[5-[6-(methylamino)pyrimidin-4-yl]pyrimidin-4-yl]amino]-N-[2-morpholin-4-yl-5-(trifluoromethyl)phenyl]benzamide Chemical compound C1=NC(NC)=CC(C=2C(=NC=NC=2)NC=2C(=CC=C(C=2)C(=O)NC=2C(=CC=C(C=2)C(F)(F)F)N2CCOCC2)C)=N1 YDUJLMHURBVFSI-UHFFFAOYSA-N 0.000 claims 1
- WAHPQGFHJBBAFR-UHFFFAOYSA-N 4-methyl-3-[[5-[6-(methylamino)pyrimidin-4-yl]pyrimidin-4-yl]amino]-N-[4-(2-oxoazetidin-1-yl)-3-(trifluoromethyl)phenyl]benzamide Chemical compound C1=NC(NC)=CC(C=2C(=NC=NC=2)NC=2C(=CC=C(C=2)C(=O)NC=2C=C(C(N3C(CC3)=O)=CC=2)C(F)(F)F)C)=N1 WAHPQGFHJBBAFR-UHFFFAOYSA-N 0.000 claims 1
- KBGSFHWAKGLIQY-UHFFFAOYSA-N 4-methyl-3-[[5-[6-(methylamino)pyrimidin-4-yl]pyrimidin-4-yl]amino]-N-[4-(trifluoromethyl)-1,3-thiazol-2-yl]benzamide Chemical compound C1=NC(NC)=CC(C=2C(=NC=NC=2)NC=2C(=CC=C(C=2)C(=O)NC=2SC=C(N=2)C(F)(F)F)C)=N1 KBGSFHWAKGLIQY-UHFFFAOYSA-N 0.000 claims 1
- HQPAPTMHPHMYTE-UHFFFAOYSA-N 4-methyl-3-[[5-[6-(methylamino)pyrimidin-4-yl]pyrimidin-4-yl]amino]-N-[4-(trifluoromethyl)pyridin-2-yl]benzamide Chemical compound C1=NC(NC)=CC(C=2C(=NC=NC=2)NC=2C(=CC=C(C=2)C(=O)NC=2N=CC=C(C=2)C(F)(F)F)C)=N1 HQPAPTMHPHMYTE-UHFFFAOYSA-N 0.000 claims 1
- XSCGABIYHGBSQU-UHFFFAOYSA-N 4-methyl-3-[[5-[6-(methylamino)pyrimidin-4-yl]pyrimidin-4-yl]amino]-N-[6-(trifluoromethyl)pyridin-2-yl]benzamide Chemical compound C1=NC(NC)=CC(C=2C(=NC=NC=2)NC=2C(=CC=C(C=2)C(=O)NC=2N=C(C=CC=2)C(F)(F)F)C)=N1 XSCGABIYHGBSQU-UHFFFAOYSA-N 0.000 claims 1
- MNLPOSRBJJSWBP-UHFFFAOYSA-N 4-methyl-3-[[5-[6-(methylamino)pyrimidin-4-yl]pyrimidin-4-yl]amino]-N-pyridin-2-ylbenzamide Chemical compound C1=NC(NC)=CC(C=2C(=NC=NC=2)NC=2C(=CC=C(C=2)C(=O)NC=2N=CC=CC=2)C)=N1 MNLPOSRBJJSWBP-UHFFFAOYSA-N 0.000 claims 1
- PDYHCMLFDFIDEM-UHFFFAOYSA-N 4-methyl-3-[[5-[6-(methylamino)pyrimidin-4-yl]pyrimidin-4-yl]amino]-N-pyridin-4-ylbenzamide Chemical compound C1=NC(NC)=CC(C=2C(=NC=NC=2)NC=2C(=CC=C(C=2)C(=O)NC=2C=CN=CC=2)C)=N1 PDYHCMLFDFIDEM-UHFFFAOYSA-N 0.000 claims 1
- 125000004195 4-methylpiperazin-1-yl group Chemical group [H]C([H])([H])N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 claims 1
- GCODGFUDHRNSAL-UHFFFAOYSA-N 5-cyclopropyl-N-[4-methyl-3-[[5-[6-(2-morpholin-4-ylethylamino)pyrimidin-4-yl]pyrimidin-4-yl]amino]phenyl]-1,2-oxazole-3-carboxamide Chemical compound C1=C(NC=2C(=CN=CN=2)C=2N=CN=C(NCCN3CCOCC3)C=2)C(C)=CC=C1NC(=O)C(=NO1)C=C1C1CC1 GCODGFUDHRNSAL-UHFFFAOYSA-N 0.000 claims 1
- CMNDAHIYNXLUQW-UHFFFAOYSA-N 5-cyclopropyl-N-[4-methyl-3-[[5-[6-(2-morpholin-4-ylethylamino)pyrimidin-4-yl]pyrimidin-4-yl]amino]phenyl]-1H-pyrazole-3-carboxamide Chemical compound C1=C(NC=2C(=CN=CN=2)C=2N=CN=C(NCCN3CCOCC3)C=2)C(C)=CC=C1NC(=O)C(NN=1)=CC=1C1CC1 CMNDAHIYNXLUQW-UHFFFAOYSA-N 0.000 claims 1
- JCWKDPVYAGOZAW-UHFFFAOYSA-N 5-tert-butyl-2-methyl-N-[4-methyl-3-[[3-[6-(2-morpholin-4-ylethylamino)pyrimidin-4-yl]pyridin-2-yl]amino]phenyl]pyrazole-3-carboxamide Chemical compound C1=C(NC=2C(=CC=CN=2)C=2N=CN=C(NCCN3CCOCC3)C=2)C(C)=CC=C1NC(=O)C1=CC(C(C)(C)C)=NN1C JCWKDPVYAGOZAW-UHFFFAOYSA-N 0.000 claims 1
- SFSXXMXHJOSBAZ-UHFFFAOYSA-N 5-tert-butyl-2-methylpyrazole-3-carboxylic acid Chemical compound CN1N=C(C(C)(C)C)C=C1C(O)=O SFSXXMXHJOSBAZ-UHFFFAOYSA-N 0.000 claims 1
- AQVXRLBEMUWSON-UHFFFAOYSA-N 5-tert-butyl-N-[3-[[3-[6-(cyclopropylamino)pyrimidin-4-yl]pyridin-2-yl]amino]-4-methylphenyl]thiophene-2-carboxamide Chemical compound C1=C(NC=2C(=CC=CN=2)C=2N=CN=C(NC3CC3)C=2)C(C)=CC=C1NC(=O)C1=CC=C(C(C)(C)C)S1 AQVXRLBEMUWSON-UHFFFAOYSA-N 0.000 claims 1
- BOBIADKAJWPJGW-UHFFFAOYSA-N 5-tert-butyl-N-[4-methyl-3-[[5-[6-(2-morpholin-4-ylethylamino)pyrimidin-4-yl]pyrimidin-4-yl]amino]phenyl]-1,2-oxazole-3-carboxamide Chemical compound C1=C(NC=2C(=CN=CN=2)C=2N=CN=C(NCCN3CCOCC3)C=2)C(C)=CC=C1NC(=O)C=1C=C(C(C)(C)C)ON=1 BOBIADKAJWPJGW-UHFFFAOYSA-N 0.000 claims 1
- ZLAYNMMROYFLEO-UHFFFAOYSA-N 5-tert-butyl-N-[4-methyl-3-[[5-[6-(2-morpholin-4-ylethylamino)pyrimidin-4-yl]pyrimidin-4-yl]amino]phenyl]thiophene-2-carboxamide Chemical compound C1=C(NC=2C(=CN=CN=2)C=2N=CN=C(NCCN3CCOCC3)C=2)C(C)=CC=C1NC(=O)C1=CC=C(C(C)(C)C)S1 ZLAYNMMROYFLEO-UHFFFAOYSA-N 0.000 claims 1
- ISLWASTVTXJHAC-UHFFFAOYSA-N N-(1-ethylpyrazol-4-yl)-4-methyl-3-[[5-[6-(methylamino)pyrimidin-4-yl]pyrimidin-4-yl]amino]benzamide Chemical compound C1=NN(CC)C=C1NC(=O)C1=CC=C(C)C(NC=2C(=CN=CN=2)C=2N=CN=C(NC)C=2)=C1 ISLWASTVTXJHAC-UHFFFAOYSA-N 0.000 claims 1
- KVMHNCNCVOJXCC-UHFFFAOYSA-N N-(2-chloropyridin-4-yl)-4-methyl-3-[[5-[6-(methylamino)pyrimidin-4-yl]pyrimidin-4-yl]amino]benzamide Chemical compound C1=NC(NC)=CC(C=2C(=NC=NC=2)NC=2C(=CC=C(C=2)C(=O)NC=2C=C(Cl)N=CC=2)C)=N1 KVMHNCNCVOJXCC-UHFFFAOYSA-N 0.000 claims 1
- ANXXDSJFEBUKGS-UHFFFAOYSA-N N-(2-methoxypyridin-4-yl)-4-methyl-3-[[5-[6-(methylamino)pyrimidin-4-yl]pyrimidin-4-yl]amino]benzamide Chemical compound C1=NC(NC)=CC(C=2C(=NC=NC=2)NC=2C(=CC=C(C=2)C(=O)NC=2C=C(OC)N=CC=2)C)=N1 ANXXDSJFEBUKGS-UHFFFAOYSA-N 0.000 claims 1
- UWVQWROSQGMHGA-UHFFFAOYSA-N N-(4-tert-butyl-1,3-thiazol-2-yl)-4-methyl-3-[[5-[6-(2-morpholin-4-ylethylamino)pyrimidin-4-yl]pyrimidin-4-yl]amino]benzamide Chemical compound CC1=CC=C(C(=O)NC=2SC=C(N=2)C(C)(C)C)C=C1NC1=NC=NC=C1C(N=CN=1)=CC=1NCCN1CCOCC1 UWVQWROSQGMHGA-UHFFFAOYSA-N 0.000 claims 1
- XFTAEXUSPSFCIO-UHFFFAOYSA-N N-(4-tert-butyl-1,3-thiazol-2-yl)-4-methyl-3-[[5-[6-(methylamino)pyrimidin-4-yl]pyrimidin-4-yl]amino]benzamide Chemical compound C1=NC(NC)=CC(C=2C(=NC=NC=2)NC=2C(=CC=C(C=2)C(=O)NC=2SC=C(N=2)C(C)(C)C)C)=N1 XFTAEXUSPSFCIO-UHFFFAOYSA-N 0.000 claims 1
- UGCJMUFCBWGTML-UHFFFAOYSA-N N-(5-tert-butyl-4-methyl-1,3-thiazol-2-yl)-4-methyl-3-[[5-[6-(methylamino)pyrimidin-4-yl]pyrimidin-4-yl]amino]benzamide Chemical compound C1=NC(NC)=CC(C=2C(=NC=NC=2)NC=2C(=CC=C(C=2)C(=O)NC=2SC(=C(C)N=2)C(C)(C)C)C)=N1 UGCJMUFCBWGTML-UHFFFAOYSA-N 0.000 claims 1
- LVVUAMDDLQJQSI-UHFFFAOYSA-N N-(6-ethylpyridin-2-yl)-4-methyl-3-[[5-[6-(methylamino)pyrimidin-4-yl]pyrimidin-4-yl]amino]benzamide Chemical compound CCC1=CC=CC(NC(=O)C=2C=C(NC=3C(=CN=CN=3)C=3N=CN=C(NC)C=3)C(C)=CC=2)=N1 LVVUAMDDLQJQSI-UHFFFAOYSA-N 0.000 claims 1
- GFZYKYGYIYJCOF-UHFFFAOYSA-N N-[2-[2-(dimethylamino)ethyl-methylamino]-5-(trifluoromethyl)phenyl]-4-methyl-3-[[3-[6-(methylamino)pyrimidin-4-yl]pyridin-2-yl]amino]benzamide Chemical compound C1=NC(NC)=CC(C=2C(=NC=CC=2)NC=2C(=CC=C(C=2)C(=O)NC=2C(=CC=C(C=2)C(F)(F)F)N(C)CCN(C)C)C)=N1 GFZYKYGYIYJCOF-UHFFFAOYSA-N 0.000 claims 1
- JGPHXOBVWJCQMR-UHFFFAOYSA-N N-[2-[2-(dimethylamino)ethyl-methylamino]-5-(trifluoromethyl)phenyl]-4-methyl-3-[[5-[6-(methylamino)pyrimidin-4-yl]pyrimidin-4-yl]amino]benzamide Chemical compound C1=NC(NC)=CC(C=2C(=NC=NC=2)NC=2C(=CC=C(C=2)C(=O)NC=2C(=CC=C(C=2)C(F)(F)F)N(C)CCN(C)C)C)=N1 JGPHXOBVWJCQMR-UHFFFAOYSA-N 0.000 claims 1
- KFAFMIVQWWKIPA-UHFFFAOYSA-N N-[2-[3-(dimethylamino)propoxy]-5-(trifluoromethyl)phenyl]-4-methyl-3-[[3-[6-(methylamino)pyrimidin-4-yl]pyridin-2-yl]amino]benzamide Chemical compound C1=NC(NC)=CC(C=2C(=NC=CC=2)NC=2C(=CC=C(C=2)C(=O)NC=2C(=CC=C(C=2)C(F)(F)F)OCCCN(C)C)C)=N1 KFAFMIVQWWKIPA-UHFFFAOYSA-N 0.000 claims 1
- YFKZBEGLYFQAFU-UHFFFAOYSA-N N-[2-[3-(dimethylamino)propoxy]-5-(trifluoromethyl)phenyl]-4-methyl-3-[[5-[6-(methylamino)pyrimidin-4-yl]pyrimidin-4-yl]amino]benzamide Chemical compound C1=NC(NC)=CC(C=2C(=NC=NC=2)NC=2C(=CC=C(C=2)C(=O)NC=2C(=CC=C(C=2)C(F)(F)F)OCCCN(C)C)C)=N1 YFKZBEGLYFQAFU-UHFFFAOYSA-N 0.000 claims 1
- KSJXHITUAGUGGB-UHFFFAOYSA-N N-[2-[3-(dimethylamino)propyl-methylamino]-5-(trifluoromethyl)phenyl]-4-methyl-3-[[5-[6-(methylamino)pyrimidin-4-yl]pyrimidin-4-yl]amino]benzamide Chemical compound C1=NC(NC)=CC(C=2C(=NC=NC=2)NC=2C(=CC=C(C=2)C(=O)NC=2C(=CC=C(C=2)C(F)(F)F)N(C)CCCN(C)C)C)=N1 KSJXHITUAGUGGB-UHFFFAOYSA-N 0.000 claims 1
- DHFBBGFHSOICHK-UHFFFAOYSA-N N-[3-[[3-(6-aminopyrimidin-4-yl)pyridin-2-yl]amino]-4-methylphenyl]-3-(1-methylpiperidin-4-yl)oxy-5-(trifluoromethyl)benzamide Chemical compound C1CN(C)CCC1OC1=CC(C(=O)NC=2C=C(NC=3C(=CC=CN=3)C=3N=CN=C(N)C=3)C(C)=CC=2)=CC(C(F)(F)F)=C1 DHFBBGFHSOICHK-UHFFFAOYSA-N 0.000 claims 1
- RNUZFAVQLYCEQA-UHFFFAOYSA-N N-[3-[[3-(6-aminopyrimidin-4-yl)pyridin-2-yl]amino]-4-methylphenyl]-3-(4-ethylpiperazin-1-yl)-5-(trifluoromethyl)benzamide Chemical compound C1CN(CC)CCN1C1=CC(C(=O)NC=2C=C(NC=3C(=CC=CN=3)C=3N=CN=C(N)C=3)C(C)=CC=2)=CC(C(F)(F)F)=C1 RNUZFAVQLYCEQA-UHFFFAOYSA-N 0.000 claims 1
- NPWXRNCXGYVJOZ-UHFFFAOYSA-N N-[3-[[3-(6-aminopyrimidin-4-yl)pyridin-2-yl]amino]-4-methylphenyl]-3-(4-methylpiperazin-1-yl)-5-(trifluoromethyl)benzamide Chemical compound C1CN(C)CCN1C1=CC(C(=O)NC=2C=C(NC=3C(=CC=CN=3)C=3N=CN=C(N)C=3)C(C)=CC=2)=CC(C(F)(F)F)=C1 NPWXRNCXGYVJOZ-UHFFFAOYSA-N 0.000 claims 1
- RSMAHGUGQAOZCZ-UHFFFAOYSA-N N-[3-[[3-(6-aminopyrimidin-4-yl)pyridin-2-yl]amino]-4-methylphenyl]-3-(trifluoromethyl)benzamide Chemical compound C1=C(NC=2C(=CC=CN=2)C=2N=CN=C(N)C=2)C(C)=CC=C1NC(=O)C1=CC=CC(C(F)(F)F)=C1 RSMAHGUGQAOZCZ-UHFFFAOYSA-N 0.000 claims 1
- NLNYYJACDUNOQP-UHFFFAOYSA-N N-[3-[[3-(6-aminopyrimidin-4-yl)pyridin-2-yl]amino]-4-methylphenyl]-3-[4-(2-hydroxyethyl)piperazin-1-yl]-5-(trifluoromethyl)benzamide Chemical compound C1=C(NC=2C(=CC=CN=2)C=2N=CN=C(N)C=2)C(C)=CC=C1NC(=O)C(C=C(C=1)C(F)(F)F)=CC=1N1CCN(CCO)CC1 NLNYYJACDUNOQP-UHFFFAOYSA-N 0.000 claims 1
- UBATYVJDOUSZHW-UHFFFAOYSA-N N-[3-[[3-(6-aminopyrimidin-4-yl)pyridin-2-yl]amino]-4-methylphenyl]-3-piperazin-1-yl-5-(trifluoromethyl)benzamide Chemical compound C1=C(NC=2C(=CC=CN=2)C=2N=CN=C(N)C=2)C(C)=CC=C1NC(=O)C(C=C(C=1)C(F)(F)F)=CC=1N1CCNCC1 UBATYVJDOUSZHW-UHFFFAOYSA-N 0.000 claims 1
- FLUGYBNGSKTJOC-UHFFFAOYSA-N N-[3-[[3-(6-aminopyrimidin-4-yl)pyridin-2-yl]amino]-4-methylphenyl]-4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)benzamide Chemical compound C1CN(C)CCN1CC1=CC=C(C(=O)NC=2C=C(NC=3C(=CC=CN=3)C=3N=CN=C(N)C=3)C(C)=CC=2)C=C1C(F)(F)F FLUGYBNGSKTJOC-UHFFFAOYSA-N 0.000 claims 1
- HIQIOAOXBWRSTE-UHFFFAOYSA-N N-[3-[[3-(6-aminopyrimidin-4-yl)pyridin-2-yl]amino]-4-methylphenyl]-5-tert-butylthiophene-2-carboxamide Chemical compound C1=C(NC=2C(=CC=CN=2)C=2N=CN=C(N)C=2)C(C)=CC=C1NC(=O)C1=CC=C(C(C)(C)C)S1 HIQIOAOXBWRSTE-UHFFFAOYSA-N 0.000 claims 1
- IVFXCXPODJQBEY-UHFFFAOYSA-N N-[3-[[3-[6-(cyclopropylamino)pyrimidin-4-yl]pyridin-2-yl]amino]-4-methylphenyl]-3-(1-methylpiperidin-4-yl)oxy-5-(trifluoromethyl)benzamide Chemical compound C1CN(C)CCC1OC1=CC(C(=O)NC=2C=C(NC=3C(=CC=CN=3)C=3N=CN=C(NC4CC4)C=3)C(C)=CC=2)=CC(C(F)(F)F)=C1 IVFXCXPODJQBEY-UHFFFAOYSA-N 0.000 claims 1
- VQMPYGWQTIMVTD-UHFFFAOYSA-N N-[3-[[3-[6-(cyclopropylamino)pyrimidin-4-yl]pyridin-2-yl]amino]-4-methylphenyl]-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide Chemical compound C1=NC(C)=CN1C1=CC(C(=O)NC=2C=C(NC=3C(=CC=CN=3)C=3N=CN=C(NC4CC4)C=3)C(C)=CC=2)=CC(C(F)(F)F)=C1 VQMPYGWQTIMVTD-UHFFFAOYSA-N 0.000 claims 1
- NDHFNNDUNPUJDB-UHFFFAOYSA-N N-[3-[[3-[6-(cyclopropylamino)pyrimidin-4-yl]pyridin-2-yl]amino]-4-methylphenyl]-3-(4-methylpiperazin-1-yl)-5-(trifluoromethyl)benzamide Chemical compound C1CN(C)CCN1C1=CC(C(=O)NC=2C=C(NC=3C(=CC=CN=3)C=3N=CN=C(NC4CC4)C=3)C(C)=CC=2)=CC(C(F)(F)F)=C1 NDHFNNDUNPUJDB-UHFFFAOYSA-N 0.000 claims 1
- DRGHPHFYOUTUGQ-UHFFFAOYSA-N N-[3-[[3-[6-(cyclopropylamino)pyrimidin-4-yl]pyridin-2-yl]amino]-4-methylphenyl]-3-(trifluoromethyl)benzamide Chemical compound C1=C(NC=2C(=CC=CN=2)C=2N=CN=C(NC3CC3)C=2)C(C)=CC=C1NC(=O)C1=CC=CC(C(F)(F)F)=C1 DRGHPHFYOUTUGQ-UHFFFAOYSA-N 0.000 claims 1
- FKNOXRUYXKJCDA-UHFFFAOYSA-N N-[3-[[3-[6-(cyclopropylamino)pyrimidin-4-yl]pyridin-2-yl]amino]-4-methylphenyl]-3-[4-(2-hydroxyethyl)piperazin-1-yl]-5-(trifluoromethyl)benzamide Chemical compound C1=C(NC=2C(=CC=CN=2)C=2N=CN=C(NC3CC3)C=2)C(C)=CC=C1NC(=O)C(C=C(C=1)C(F)(F)F)=CC=1N1CCN(CCO)CC1 FKNOXRUYXKJCDA-UHFFFAOYSA-N 0.000 claims 1
- HIWIEOUFBNLFJI-UHFFFAOYSA-N N-[3-[[3-[6-(cyclopropylamino)pyrimidin-4-yl]pyridin-2-yl]amino]-4-methylphenyl]-4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)benzamide Chemical compound C1CN(CC)CCN1CC1=CC=C(C(=O)NC=2C=C(NC=3C(=CC=CN=3)C=3N=CN=C(NC4CC4)C=3)C(C)=CC=2)C=C1C(F)(F)F HIWIEOUFBNLFJI-UHFFFAOYSA-N 0.000 claims 1
- CPDFZXOKBREOPA-UHFFFAOYSA-N N-[3-[[3-[6-[[4-[(dimethylamino)methyl]pyridin-2-yl]amino]pyrimidin-4-yl]pyridin-2-yl]amino]-4-methylphenyl]-3-(trifluoromethyl)benzamide Chemical compound CN(C)CC1=CC=NC(NC=2N=CN=C(C=2)C=2C(=NC=CC=2)NC=2C(=CC=C(NC(=O)C=3C=C(C=CC=3)C(F)(F)F)C=2)C)=C1 CPDFZXOKBREOPA-UHFFFAOYSA-N 0.000 claims 1
- MNDCBTCEORGNDO-UHFFFAOYSA-N N-[3-[[3-[6-[[5-[(dimethylamino)methyl]pyridin-2-yl]amino]pyrimidin-4-yl]pyridin-2-yl]amino]-4-methylphenyl]-3-(trifluoromethyl)benzamide Chemical compound N1=CC(CN(C)C)=CC=C1NC1=CC(C=2C(=NC=CC=2)NC=2C(=CC=C(NC(=O)C=3C=C(C=CC=3)C(F)(F)F)C=2)C)=NC=N1 MNDCBTCEORGNDO-UHFFFAOYSA-N 0.000 claims 1
- PGRYCRXYKIHVOV-UHFFFAOYSA-N N-[3-[[5-(6-aminopyrimidin-4-yl)pyrimidin-4-yl]amino]-4-methylphenyl]-3-(trifluoromethyl)benzamide Chemical compound C1=C(NC=2C(=CN=CN=2)C=2N=CN=C(N)C=2)C(C)=CC=C1NC(=O)C1=CC=CC(C(F)(F)F)=C1 PGRYCRXYKIHVOV-UHFFFAOYSA-N 0.000 claims 1
- YYOGMILVPZTMCE-UHFFFAOYSA-N N-[3-[[5-(6-hydrazinylpyrimidin-4-yl)pyrimidin-4-yl]amino]-4-methylphenyl]-3-(trifluoromethyl)benzamide Chemical compound C1=C(NC=2C(=CN=CN=2)C=2N=CN=C(NN)C=2)C(C)=CC=C1NC(=O)C1=CC=CC(C(F)(F)F)=C1 YYOGMILVPZTMCE-UHFFFAOYSA-N 0.000 claims 1
- LGBYMWCILRBYHA-UHFFFAOYSA-N N-[3-[[5-[6-(cyclopropylamino)pyrimidin-4-yl]pyrimidin-4-yl]amino]-4-methylphenyl]-3-(4-ethylpiperazin-1-yl)-5-(trifluoromethyl)benzamide Chemical compound C1CN(CC)CCN1C1=CC(C(=O)NC=2C=C(NC=3C(=CN=CN=3)C=3N=CN=C(NC4CC4)C=3)C(C)=CC=2)=CC(C(F)(F)F)=C1 LGBYMWCILRBYHA-UHFFFAOYSA-N 0.000 claims 1
- OPKKFZVUNBABJP-UHFFFAOYSA-N N-[3-[[5-[6-(cyclopropylamino)pyrimidin-4-yl]pyrimidin-4-yl]amino]-4-methylphenyl]-3-(4-methylpiperazin-1-yl)-5-(trifluoromethyl)benzamide Chemical compound C1CN(C)CCN1C1=CC(C(=O)NC=2C=C(NC=3C(=CN=CN=3)C=3N=CN=C(NC4CC4)C=3)C(C)=CC=2)=CC(C(F)(F)F)=C1 OPKKFZVUNBABJP-UHFFFAOYSA-N 0.000 claims 1
- TVUSVAUCJJVWHA-UHFFFAOYSA-N N-[3-[[5-[6-(cyclopropylamino)pyrimidin-4-yl]pyrimidin-4-yl]amino]-4-methylphenyl]-3-[4-(2-hydroxyethyl)piperazin-1-yl]-5-(trifluoromethyl)benzamide Chemical compound C1=C(NC=2C(=CN=CN=2)C=2N=CN=C(NC3CC3)C=2)C(C)=CC=C1NC(=O)C(C=C(C=1)C(F)(F)F)=CC=1N1CCN(CCO)CC1 TVUSVAUCJJVWHA-UHFFFAOYSA-N 0.000 claims 1
- QMJVJGVPJJHGOC-UHFFFAOYSA-N N-[3-[[5-[6-(cyclopropylamino)pyrimidin-4-yl]pyrimidin-4-yl]amino]-4-methylphenyl]-4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)benzamide Chemical compound C1CN(CC)CCN1CC1=CC=C(C(=O)NC=2C=C(NC=3C(=CN=CN=3)C=3N=CN=C(NC4CC4)C=3)C(C)=CC=2)C=C1C(F)(F)F QMJVJGVPJJHGOC-UHFFFAOYSA-N 0.000 claims 1
- QYEKACWCARQWAF-UHFFFAOYSA-N N-[3-[[5-[6-(ethylamino)pyrimidin-4-yl]pyrimidin-4-yl]amino]-4-methylphenyl]-3-(trifluoromethyl)benzamide Chemical compound C1=NC(NCC)=CC(C=2C(=NC=NC=2)NC=2C(=CC=C(NC(=O)C=3C=C(C=CC=3)C(F)(F)F)C=2)C)=N1 QYEKACWCARQWAF-UHFFFAOYSA-N 0.000 claims 1
- UAUMKQUNJATMGQ-UHFFFAOYSA-N N-[4-chloro-3-(trifluoromethyl)phenyl]-4-methyl-3-[[3-[6-(2-morpholin-4-ylethylamino)pyrimidin-4-yl]pyridin-2-yl]amino]benzamide Chemical compound CC1=CC=C(C(=O)NC=2C=C(C(Cl)=CC=2)C(F)(F)F)C=C1NC1=NC=CC=C1C(N=CN=1)=CC=1NCCN1CCOCC1 UAUMKQUNJATMGQ-UHFFFAOYSA-N 0.000 claims 1
- PRYMPBIXTQPCGS-UHFFFAOYSA-N N-[4-methyl-3-[[3-[6-(2-morpholin-4-ylethylamino)pyrimidin-4-yl]pyridin-2-yl]amino]phenyl]-3-(1-methylpiperidin-4-yl)oxy-5-(trifluoromethyl)benzamide Chemical compound C1CN(C)CCC1OC1=CC(C(=O)NC=2C=C(NC=3C(=CC=CN=3)C=3N=CN=C(NCCN4CCOCC4)C=3)C(C)=CC=2)=CC(C(F)(F)F)=C1 PRYMPBIXTQPCGS-UHFFFAOYSA-N 0.000 claims 1
- RTYUNKXKFHNAIU-UHFFFAOYSA-N N-[4-methyl-3-[[3-[6-[[4-(morpholin-4-ylmethyl)pyridin-2-yl]amino]pyrimidin-4-yl]pyridin-2-yl]amino]phenyl]-3-(trifluoromethyl)benzamide Chemical compound C1=C(NC=2C(=CC=CN=2)C=2N=CN=C(NC=3N=CC=C(CN4CCOCC4)C=3)C=2)C(C)=CC=C1NC(=O)C1=CC=CC(C(F)(F)F)=C1 RTYUNKXKFHNAIU-UHFFFAOYSA-N 0.000 claims 1
- WTBQSZKOVJDFKJ-UHFFFAOYSA-N N-[4-methyl-3-[[3-[6-[[5-(morpholin-4-ylmethyl)pyridin-2-yl]amino]pyrimidin-4-yl]pyridin-2-yl]amino]phenyl]-3-(trifluoromethyl)benzamide Chemical compound C1=C(NC=2C(=CC=CN=2)C=2N=CN=C(NC=3N=CC(CN4CCOCC4)=CC=3)C=2)C(C)=CC=C1NC(=O)C1=CC=CC(C(F)(F)F)=C1 WTBQSZKOVJDFKJ-UHFFFAOYSA-N 0.000 claims 1
- ZHTZBMAATBETDD-UHFFFAOYSA-N N-[4-methyl-3-[[5-[6-(2-morpholin-4-ylethylamino)pyrimidin-4-yl]pyrimidin-4-yl]amino]phenyl]-3-(trifluoromethyl)benzamide Chemical compound C1=C(NC=2C(=CN=CN=2)C=2N=CN=C(NCCN3CCOCC3)C=2)C(C)=CC=C1NC(=O)C1=CC=CC(C(F)(F)F)=C1 ZHTZBMAATBETDD-UHFFFAOYSA-N 0.000 claims 1
- DQDKVXIDVZTXLQ-UHFFFAOYSA-N N-[4-methyl-3-[[5-[6-(2-pyrrolidin-1-ylethylamino)pyrimidin-4-yl]pyrimidin-4-yl]amino]phenyl]-3-(trifluoromethyl)benzamide Chemical compound C1=C(NC=2C(=CN=CN=2)C=2N=CN=C(NCCN3CCCC3)C=2)C(C)=CC=C1NC(=O)C1=CC=CC(C(F)(F)F)=C1 DQDKVXIDVZTXLQ-UHFFFAOYSA-N 0.000 claims 1
- XAIKRQIKOKXJLN-UHFFFAOYSA-N N-[4-methyl-3-[[5-[6-(methylamino)pyrimidin-4-yl]pyrimidin-4-yl]amino]phenyl]-3-(trifluoromethyl)benzamide Chemical compound C1=NC(NC)=CC(C=2C(=NC=NC=2)NC=2C(=CC=C(NC(=O)C=3C=C(C=CC=3)C(F)(F)F)C=2)C)=N1 XAIKRQIKOKXJLN-UHFFFAOYSA-N 0.000 claims 1
- XQMXAHDHDJSDIT-UHFFFAOYSA-N N-[4-methyl-3-[[5-[6-(piperidin-4-ylamino)pyrimidin-4-yl]pyrimidin-4-yl]amino]phenyl]-3-(trifluoromethyl)benzamide Chemical compound C1=C(NC=2C(=CN=CN=2)C=2N=CN=C(NC3CCNCC3)C=2)C(C)=CC=C1NC(=O)C1=CC=CC(C(F)(F)F)=C1 XQMXAHDHDJSDIT-UHFFFAOYSA-N 0.000 claims 1
- OOYYFVNGRAYGSQ-UHFFFAOYSA-N N-[4-methyl-3-[[5-[6-(piperidin-4-ylmethylamino)pyrimidin-4-yl]pyrimidin-4-yl]amino]phenyl]-3-(trifluoromethyl)benzamide Chemical compound C1=C(NC=2C(=CN=CN=2)C=2N=CN=C(NCC3CCNCC3)C=2)C(C)=CC=C1NC(=O)C1=CC=CC(C(F)(F)F)=C1 OOYYFVNGRAYGSQ-UHFFFAOYSA-N 0.000 claims 1
- PHOPGVMFTYUQTF-UHFFFAOYSA-N N-[4-methyl-3-[[5-[6-(propan-2-ylamino)pyrimidin-4-yl]pyrimidin-4-yl]amino]phenyl]-3-(trifluoromethyl)benzamide Chemical compound C1=NC(NC(C)C)=CC(C=2C(=NC=NC=2)NC=2C(=CC=C(NC(=O)C=3C=C(C=CC=3)C(F)(F)F)C=2)C)=N1 PHOPGVMFTYUQTF-UHFFFAOYSA-N 0.000 claims 1
- ZHIWQIIIQMHFGX-UHFFFAOYSA-N N-[4-methyl-3-[[5-[6-[(1-methylpiperidin-4-yl)amino]pyrimidin-4-yl]pyrimidin-4-yl]amino]phenyl]-3-(trifluoromethyl)benzamide Chemical compound C1CN(C)CCC1NC1=CC(C=2C(=NC=NC=2)NC=2C(=CC=C(NC(=O)C=3C=C(C=CC=3)C(F)(F)F)C=2)C)=NC=N1 ZHIWQIIIQMHFGX-UHFFFAOYSA-N 0.000 claims 1
- WTAIPDRAQMCFLP-UHFFFAOYSA-N N-[4-methyl-3-[[5-[6-[(4-methylpiperazin-1-yl)amino]pyrimidin-4-yl]pyrimidin-4-yl]amino]phenyl]-3-(trifluoromethyl)benzamide Chemical compound C1CN(C)CCN1NC1=CC(C=2C(=NC=NC=2)NC=2C(=CC=C(NC(=O)C=3C=C(C=CC=3)C(F)(F)F)C=2)C)=NC=N1 WTAIPDRAQMCFLP-UHFFFAOYSA-N 0.000 claims 1
- HNYXLMGNKZHXPS-UHFFFAOYSA-N N-[4-methyl-3-[[5-[6-[2-(4-methylpiperazin-1-yl)ethylamino]pyrimidin-4-yl]pyrimidin-4-yl]amino]phenyl]-3-(trifluoromethyl)benzamide Chemical compound C1CN(C)CCN1CCNC1=CC(C=2C(=NC=NC=2)NC=2C(=CC=C(NC(=O)C=3C=C(C=CC=3)C(F)(F)F)C=2)C)=NC=N1 HNYXLMGNKZHXPS-UHFFFAOYSA-N 0.000 claims 1
- VSAOZHRIRXZVAK-UHFFFAOYSA-N N-[4-methyl-3-[[5-[6-[3-(4-methylpiperazin-1-yl)propylamino]pyrimidin-4-yl]pyrimidin-4-yl]amino]phenyl]-3-(trifluoromethyl)benzamide Chemical compound C1CN(C)CCN1CCCNC1=CC(C=2C(=NC=NC=2)NC=2C(=CC=C(NC(=O)C=3C=C(C=CC=3)C(F)(F)F)C=2)C)=NC=N1 VSAOZHRIRXZVAK-UHFFFAOYSA-N 0.000 claims 1
- 230000002730 additional Effects 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 230000000996 additive Effects 0.000 claims 1
- 125000003277 amino group Chemical group 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- KOFZWWMCDUHEEM-UHFFFAOYSA-N 1-methylpyrrolidine Chemical group [CH2]N1CCCC1 KOFZWWMCDUHEEM-UHFFFAOYSA-N 0.000 description 1
- 150000001204 N-oxides Chemical class 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N ethylene glycol monomethyl ether Chemical group COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 239000000651 prodrug Substances 0.000 description 1
- 229940002612 prodrugs Drugs 0.000 description 1
Description
æ¬çºæã®æŠèŠ
äžã€ã®åŽé¢ã§ã¯ãæ¬çºæã¯åŒïŒ©ïŒ
[åŒäžïŒ
ïŒã¯âïŒïŒ²ïŒããã³âïŒïŒ£()ïŒããéžæããïŒããã«ïŒ²ïŒã¯æ°ŽçŽ ããã³ïŒ£ïŒâïŒã¢ã«ãã«ããéžæããïŒïŒ²ïŒã¯æ°ŽçŽ ãïŒâïŒã¢ã«ãã«ãâïŒïŒ²ïŒïŒãïŒâïŒïŒâã¢ãªãŒã«âïŒâïŒã¢ã«ãã«ãïŒâïŒïŒâãããã¢ãªãŒã«âïŒâïŒâã¢ã«ãã«ãïŒâïŒïŒâã·ã¯ãã¢ã«ãã«âïŒâïŒâã¢ã«ãã«ããã³ïŒ£ïŒâïŒâãããã·ã¯ãã¢ã«ãã«âïŒâïŒâã¢ã«ãã«ããéžæããïŒããã«ïŒ²ïŒã®ã¢ãªãŒã«ããããã¢ãªãŒã«ãã·ã¯ãã¢ã«ãã«ãŸãã¯ãããã·ã¯ãã¢ã«ãã«ã¯ããããææã«ããïŒâïŒâã¢ã«ãã«ãïŒâïŒâã¢ã«ã³ãã·ãâïŒïŒ²ïŒïŒããã³ïŒ£ïŒâïŒâãããã·ã¯ãã¢ã«ãã«âïŒâïŒâã¢ã«ãã«ããç¬ç«ã«éžæãããåºïŒåãïŒåã§çœ®æãããŠããŠããïŒããã«ïŒ±ã¯çµåããã³ïŒ£ïŒâïŒâã¢ã«ãã¬ã³ããéžæããïŒããã«ïŒ²ïŒã¯æ°ŽçŽ ããã³ïŒ£ïŒâïŒâã¢ã«ãã«ããéžæããïŒããã«ïŒ²ïŒããã³ïŒ²ïŒïŒã¯æ°ŽçŽ ããã³ïŒ£ïŒâïŒâã¢ã«ãã«ããç¬ç«ã«éžæããïŒ
ïŒã¯æ°ŽçŽ ããã³ïŒ£ïŒâïŒâã¢ã«ãã«ããéžæããïŒ
ïŒã¯æ°ŽçŽ ããã³ïŒ£ïŒâïŒâã¢ã«ãã«ããéžæããïŒ
ïŒã¯æ°ŽçŽ ããããïŒâïŒâã¢ã«ãã«ãïŒâïŒâã¢ã«ã³ãã·ããã眮æâïŒâïŒâã¢ã«ãã«ããã³ãã眮æâïŒâïŒâã¢ã«ã³ãã·ããéžæããïŒ
ïŒã¯â()ïŒïŒããã³â()ïŒïŒããéžæããïŒããã«ïŒ²ïŒïŒã¯ïŒ£ïŒâïŒïŒâã¢ãªãŒã«ããã³ïŒ£ïŒâïŒïŒâãããã¢ãªãŒã«ããéžæããïŒããã«ïŒ²ïŒïŒã®ã¢ãªãŒã«ãŸãã¯ãããã¢ãªãŒã«ã¯ããããææã«ãããããïŒâïŒâã¢ã«ãã«ãïŒâïŒâã¢ã«ã³ãã·ããã眮æâïŒâïŒâã¢ã«ãã«ããã眮æâïŒâïŒâã¢ã«ã³ãã·ããžâïŒâïŒâã¢ã«ãã«ã¢ããâïŒâïŒâã¢ã«ã³ãã·ããžâïŒâïŒâã¢ã«ãã«âã¢ããâïŒâïŒâã¢ã«ãã«(ïŒâïŒâã¢ã«ãã«)ã¢ãããïŒâïŒïŒâãããã¢ãªãŒã«âïŒâïŒâã¢ã«ãã«ãïŒâïŒâãããã·ã¯ãã¢ã«ãã«âïŒâïŒâã¢ã«ãã«ããã³ïŒ£ïŒâïŒâãããã·ã¯ãã¢ã«ãã«ãªãã·ããç¬ç«ã«éžæãããåºïŒåãïŒåã§çœ®æãããŠããŠããïŒããã«ïŒ²ïŒïŒã®ãããã¢ãªãŒã«ãŸãã¯ãããã·ã¯ãã¢ã«ãã«ã®çœ®æåºã¯ããããããã«ææã«ããïŒâïŒâã¢ã«ãã«ããã³ããããã·âïŒâïŒâã¢ã«ãã«ããç¬ç«ã«éžæãããåºïŒåãïŒåã§çœ®æãããŠããŠããïŒãããŠ
ããã³ïŒ¹ã¯ïŒ®ããã³ïŒ£ïŒšããç¬ç«ã«éžæãããã]
ã§ç€ºãããååç©ããã³ãã®ïŒ®âãªãã·ãèªå°äœããããã©ãã°èªå°äœãä¿è·èªå°äœãåã ã®ç°æ§äœããã³ç°æ§äœæ··åç©ïŒããã³ãã®ååç©ã®å»è¬çã«èš±å®¹ãããå¡©ããã³æº¶åªåç©(ããšãã°ãæ°Žåç©)ãæäŸããã
äžã€ã®åŽé¢ã§ã¯ãæ¬çºæã¯åŒïŒ©ïŒ
ïŒã¯âïŒïŒ²ïŒããã³âïŒïŒ£()ïŒããéžæããïŒããã«ïŒ²ïŒã¯æ°ŽçŽ ããã³ïŒ£ïŒâïŒã¢ã«ãã«ããéžæããïŒïŒ²ïŒã¯æ°ŽçŽ ãïŒâïŒã¢ã«ãã«ãâïŒïŒ²ïŒïŒãïŒâïŒïŒâã¢ãªãŒã«âïŒâïŒã¢ã«ãã«ãïŒâïŒïŒâãããã¢ãªãŒã«âïŒâïŒâã¢ã«ãã«ãïŒâïŒïŒâã·ã¯ãã¢ã«ãã«âïŒâïŒâã¢ã«ãã«ããã³ïŒ£ïŒâïŒâãããã·ã¯ãã¢ã«ãã«âïŒâïŒâã¢ã«ãã«ããéžæããïŒããã«ïŒ²ïŒã®ã¢ãªãŒã«ããããã¢ãªãŒã«ãã·ã¯ãã¢ã«ãã«ãŸãã¯ãããã·ã¯ãã¢ã«ãã«ã¯ããããææã«ããïŒâïŒâã¢ã«ãã«ãïŒâïŒâã¢ã«ã³ãã·ãâïŒïŒ²ïŒïŒããã³ïŒ£ïŒâïŒâãããã·ã¯ãã¢ã«ãã«âïŒâïŒâã¢ã«ãã«ããç¬ç«ã«éžæãããåºïŒåãïŒåã§çœ®æãããŠããŠããïŒããã«ïŒ±ã¯çµåããã³ïŒ£ïŒâïŒâã¢ã«ãã¬ã³ããéžæããïŒããã«ïŒ²ïŒã¯æ°ŽçŽ ããã³ïŒ£ïŒâïŒâã¢ã«ãã«ããéžæããïŒããã«ïŒ²ïŒããã³ïŒ²ïŒïŒã¯æ°ŽçŽ ããã³ïŒ£ïŒâïŒâã¢ã«ãã«ããç¬ç«ã«éžæããïŒ
ïŒã¯æ°ŽçŽ ããã³ïŒ£ïŒâïŒâã¢ã«ãã«ããéžæããïŒ
ïŒã¯æ°ŽçŽ ããã³ïŒ£ïŒâïŒâã¢ã«ãã«ããéžæããïŒ
ïŒã¯æ°ŽçŽ ããããïŒâïŒâã¢ã«ãã«ãïŒâïŒâã¢ã«ã³ãã·ããã眮æâïŒâïŒâã¢ã«ãã«ããã³ãã眮æâïŒâïŒâã¢ã«ã³ãã·ããéžæããïŒ
ïŒã¯â()ïŒïŒããã³â()ïŒïŒããéžæããïŒããã«ïŒ²ïŒïŒã¯ïŒ£ïŒâïŒïŒâã¢ãªãŒã«ããã³ïŒ£ïŒâïŒïŒâãããã¢ãªãŒã«ããéžæããïŒããã«ïŒ²ïŒïŒã®ã¢ãªãŒã«ãŸãã¯ãããã¢ãªãŒã«ã¯ããããææã«ãããããïŒâïŒâã¢ã«ãã«ãïŒâïŒâã¢ã«ã³ãã·ããã眮æâïŒâïŒâã¢ã«ãã«ããã眮æâïŒâïŒâã¢ã«ã³ãã·ããžâïŒâïŒâã¢ã«ãã«ã¢ããâïŒâïŒâã¢ã«ã³ãã·ããžâïŒâïŒâã¢ã«ãã«âã¢ããâïŒâïŒâã¢ã«ãã«(ïŒâïŒâã¢ã«ãã«)ã¢ãããïŒâïŒïŒâãããã¢ãªãŒã«âïŒâïŒâã¢ã«ãã«ãïŒâïŒâãããã·ã¯ãã¢ã«ãã«âïŒâïŒâã¢ã«ãã«ããã³ïŒ£ïŒâïŒâãããã·ã¯ãã¢ã«ãã«ãªãã·ããç¬ç«ã«éžæãããåºïŒåãïŒåã§çœ®æãããŠããŠããïŒããã«ïŒ²ïŒïŒã®ãããã¢ãªãŒã«ãŸãã¯ãããã·ã¯ãã¢ã«ãã«ã®çœ®æåºã¯ããããããã«ææã«ããïŒâïŒâã¢ã«ãã«ããã³ããããã·âïŒâïŒâã¢ã«ãã«ããç¬ç«ã«éžæãããåºïŒåãïŒåã§çœ®æãããŠããŠããïŒãããŠ
ããã³ïŒ¹ã¯ïŒ®ããã³ïŒ£ïŒšããç¬ç«ã«éžæãããã]
ã§ç€ºãããååç©ããã³ãã®ïŒ®âãªãã·ãèªå°äœããããã©ãã°èªå°äœãä¿è·èªå°äœãåã ã®ç°æ§äœããã³ç°æ§äœæ··åç©ïŒããã³ãã®ååç©ã®å»è¬çã«èš±å®¹ãããå¡©ããã³æº¶åªåç©(ããšãã°ãæ°Žåç©)ãæäŸããã
ä»ã®æ
æ§ã§ã¯ãïŒã¯âïŒããã³â()ïŒããéžæããïŒããã«ïŒ²ïŒã¯ïŒæ°ŽçŽ ïŒã¢ããïŒã¡ãã«ïŒãšãã«ïŒã€ãœãããã«ïŒã·ã¯ããããã«ïŒã¢ã«ããªããšãã«ïŒææã«ããïŒåãïŒåã®ã¡ããã·åºã§çœ®æãããŠããŠããããã³ãžã«ïŒã¢ã«ããªãâã¡ãã«ããžã¡ãã«âã¢ããâãšãã«ããã³ãžã¡ãã«âã¢ããâã¡ãã«ããéžæãããåºã§çœ®æãããããªãžãã«ïŒã¡ãã«âããã©ãžãã«âãšãã«ïŒããã©ãžãã«âãšãã«ïŒã¡ãã«âããã©ãžãã«âãããã«ïŒãããªãžãã«âãšãã«ïŒææã«ãããšãã«ã§çœ®æãããŠããŠããããããªãžãã«âã¡ãã«ïŒãããªãžãã«âã¡ãã«ïŒææã«ããã¡ãã«ã§çœ®æãããŠããŠããããããªãžãã«ïŒããã³ã¡ãã«âããã©ãžãã«ããéžæããïŒãããŠïŒ²ïŒã¯ã¡ãã«ã§ããã
å¥ãªäžæ
æ§ã§ã¯ãïŒã¯ã¡ãã«ã§ããïŒãããŠïŒ²ïŒã¯â()ïŒïŒããã³â()ïŒïŒããéžæããïŒããã«ïŒ²ïŒïŒã¯ãã§ãã«ãïŒâãªããœãããªãžã³âïŒâã€ã«ãïŒ,ïŒ,ïŒâãã¢ãžã¢ãŸãªã«ãããªãžãã«ããã©ãŸãªã«ãããšãã«ãã€ãœãªããµãŸãªã«ããã³ãã¢ãŸãªã«ããéžæããïŒãã®ãã§ãã«ããã©ãŸãªã«ãããšãã«ãïŒâãªããœãããªãžã³âïŒâã€ã«ãïŒ,ïŒ,ïŒâãã¢ãžã¢ãŸãªã«ãããªãžãã«ãã€ãœãªããµãŸãªã«ãŸãã¯ãã¢ãŸãªã«ã¯ãææã«ãããããããªãã«ãªãã¡ãã«ãã¡ãã«âããã©ãžãã«ããšãã«âããã©ãžãã«ãïŒâãªããœã¢ãŒããžã³âïŒâã€ã«ãã¢ã«ããªããã¢ã«ããªãâã¡ãã«ãããããã·âãšãã«âããã©ãžãã«ããžã¡ãã«ã¢ããâãšãã«â(ã¡ãã«)ã¢ããããžã¡ãã«ã¢ããâãããã«â(ã¡ãã«)ã¢ãããã¡ãã«âã€ãããŸãªã«ãã¡ãã«ãã€ãœãããã«ãtâããã«ãã¡ããã·ãã¡ãã«âãããªãžãã«âãªãã·ãã¡ãã«âããã©ãžãã«âã¡ãã«ããšãã«âããã©ãžãã«âã¡ãã«ããšãã«ããã³ã·ã¯ããããã«ããç¬ç«ã«éžæãããåºïŒåãïŒåã§çœ®æãããŠããŠãããã
Claims (9)
- åŒïŒ©ïŒ
ïŒã¯âïŒïŒ²ïŒããã³âïŒïŒ£()ïŒããéžæããïŒããã«ãïŒã¯æ°ŽçŽ ããã³ïŒ£ïŒâïŒâã¢ã«ãã«ããéžæããïŒïŒ²ïŒã¯æ°ŽçŽ ãïŒâïŒã¢ã«ãã«ãâïŒïŒ²ïŒïŒãïŒâïŒïŒâã¢ãªãŒã«âïŒâïŒâã¢ã«ãã«ãïŒâïŒïŒâãããã¢ãªãŒã«âïŒâïŒâã¢ã«ãã«ãïŒâïŒïŒâã·ã¯ãã¢ã«ãã«âïŒâïŒâã¢ã«ãã«ããã³ïŒ£ïŒâïŒâãããã·ã¯ãã¢ã«ãã«âïŒâïŒâã¢ã«ãã«ããéžæããïŒããã«ïŒ²ïŒã®ã¢ãªãŒã«ããããã¢ãªãŒã«ãã·ã¯ãã¢ã«ãã«ãŸãã¯ãããã·ã¯ãã¢ã«ãã«ã¯ããããææã«ããïŒâïŒâã¢ã«ãã«ãïŒâïŒâã¢ã«ã³ãã·ãâïŒïŒ²ïŒïŒããã³ïŒ£ïŒâïŒâãããã·ã¯ãã¢ã«ãã«âïŒâïŒâã¢ã«ãã«ããç¬ç«ã«éžæãããåºïŒåãïŒåã«ãã£ãŠçœ®æãããŠããŠããïŒããã«ïŒ±ã¯çµåããã³ïŒ£ïŒâïŒã¢ã«ãã¬ã³ããéžæããïŒããã«ïŒ²ïŒã¯æ°ŽçŽ ããã³ïŒ£ïŒâïŒâã¢ã«ãã«ããéžæããïŒããã«ïŒ²ïŒããã³ïŒ²ïŒïŒã¯æ°ŽçŽ ããã³ïŒ£ïŒâïŒâã¢ã«ãã«ããç¬ç«ã«éžæããïŒ
ïŒã¯æ°ŽçŽ ããã³ïŒ£ïŒâïŒã¢ã«ãã«ããéžæããïŒ
ïŒã¯æ°ŽçŽ ããã³ïŒ£ïŒâïŒã¢ã«ãã«ããéžæããïŒ
ïŒã¯æ°ŽçŽ ããããïŒâïŒâã¢ã«ãã«ãïŒâïŒâã¢ã«ã³ãã·ããã眮æâïŒâïŒâã¢ã«ãã«ããã³ãã眮æâïŒâïŒâã¢ã«ã³ãã·ããéžæããïŒ
ïŒã¯â()ïŒïŒããã³â()ïŒïŒããéžæããïŒããã«ïŒ²ïŒïŒã¯ïŒ£ïŒâïŒïŒâã¢ãªãŒã«ããã³ïŒ£ïŒâïŒïŒâãããã¢ãªãŒã«ããéžæããïŒããã«ïŒ²ïŒïŒã®ã¢ãªãŒã«ãŸãã¯ãããã¢ãªãŒã«ã¯ããããææã«ãããããïŒâïŒâã¢ã«ãã«ãïŒâïŒâã¢ã«ã³ãã·ããã眮æâïŒâïŒâã¢ã«ãã«ããã眮æâïŒâïŒâã¢ã«ã³ãã·ããžâïŒâïŒâã¢ã«ãã«ã¢ããâïŒâïŒâã¢ã«ã³ãã·ããžâïŒâïŒâã¢ã«ãã«âã¢ããâïŒâïŒâã¢ã«ãã«(ïŒâïŒã¢ã«ãã«)ã¢ãããïŒâïŒïŒâãããã¢ãªãŒã«âïŒâïŒã¢ã«ãã«ãïŒâïŒâãããã·ã¯ãã¢ã«ãã«âïŒâïŒâã¢ã«ãã«ããã³ïŒ£ïŒâïŒâãããã·ã¯ãã¢ã«ãã«ãªãã·ããç¬ç«ã«éžæãããåºïŒåãïŒåã§çœ®æãããŠããŠããïŒããã«ïŒ²ïŒïŒã®ãããã¢ãªãŒã«ãŸãã¯ãããã·ã¯ãã¢ã«ãã«çœ®æåºã¯ããããããã«ææã«ããïŒâïŒâã¢ã«ãã«ããã³ããããã·âïŒâïŒâã¢ã«ãã«ããç¬ç«ã«éžæãããåºïŒåãïŒåã§çœ®æãããŠããŠããïŒãããŠ
ããã³ïŒ¹ã¯ïŒ®ããã³ïŒ£ïŒšããç¬ç«ã«éžæããã]
ã§ç€ºãããååç©ããŸãã¯ãã®å»è¬çã«èš±å®¹ãããå¡©ãæ°Žåç©ã溶åªåç©ãããã¯ç°æ§äœã - ãã§ããããããã³ïŒ®ããéžæããïŒïŒ²ïŒãæ°ŽçŽ ã§ããããããŠïŒ²ïŒãæ°ŽçŽ ã§ãããè«æ±é ïŒã«èšèŒã®ååç©ã
- ïŒãâïŒããã³â()ïŒããéžæããïŒããã«ïŒ²ïŒãæ°ŽçŽ ïŒã¢ããïŒã¡ãã«ïŒãšãã«ïŒã€ãœãããã«ïŒã·ã¯ããããã«ïŒã¢ã«ããªãâãšãã«ïŒææã«ããïŒåãïŒåã®ã¡ããã·åºã§çœ®æãããŠããŠããããã³ãžã«ïŒã¢ã«ããªãã¡ãã«ããžã¡ãã«ã¢ããâãšãã«ããã³ãžã¡ãã«ã¢ããâã¡ãã«ããéžæãããåºã§çœ®æãããããªãžãã«ïŒã¡ãã«âããã©ãžãã«âãšãã«ïŒããã©ãžãã«âãšãã«ïŒã¡ãã«âããã©ãžãã«âãããã«ïŒãããªãžãã«âãšãã«ïŒææã«ãããšãã«ã§çœ®æãããŠããŠããããããªãžãã«âã¡ãã«ïŒãããªãžãã«âã¡ãã«ïŒææã«ããã¡ãã«ã§çœ®æãããŠããŠããããããªãžãã«ïŒããã³ã¡ãã«âããã©ãžãã«ããéžæããïŒãããŠïŒ²ïŒãã¡ãã«ã§ãããè«æ±é ïŒã«èšèŒã®ååç©ã
- ïŒãã¡ãã«ã§ããïŒãããŠïŒ²ïŒãâ()ïŒïŒããã³â()ïŒïŒããéžæããïŒããã«ïŒ²ïŒïŒããã§ãã«ãïŒâãªããœãããªãžã³âïŒâã€ã«ãïŒ,ïŒ,ïŒâãã¢ãžã¢ãŸãªã«ãããªãžãã«ããã©ãŸãªã«ãããšãã«ãã€ãœãªããµãŸãªã«ããã³ãã¢ãŸãªã«ããéžæããïŒããã«åèšãã§ãã«ããã©ãŸãªã«ãããšãã«ãïŒâãªããœãããªãžã³âïŒâã€ã«ãïŒ,ïŒ,ïŒâãã¢ãžã¢ãŸãªã«ãããªãžãã«ãã€ãœãªããµãŸãªã«ãŸãã¯ãã¢ãŸãªã«ã¯ãææã«ãããããããªãã«ãªãã¡ãã«ãã¡ãã«âããã©ãžãã«ããšãã«âããã©ãžãã«ãïŒâãªããœã¢ãŒããžã³âïŒâã€ã«ãã¢ã«ããªããã¢ã«ããªãã¡ãã«ãããããã·âãšãã«âããã©ãžãã«ããžã¡ãã«ã¢ãããšãã«â(ã¡ãã«)ã¢ããããžã¡ãã«ã¢ããâãããã«â(ã¡ãã«)ã¢ãããã¡ãã«âã€ãããŸãªã«ãã¡ãã«ãã€ãœãããã«ãïœâããã«ãã¡ããã·ãã¡ãã«âãããªãžãã«ãªãã·ãã¡ãã«âããã©ãžãã«âã¡ãã«ããšãã«âããã©ãžãã«âã¡ãã«ããšãã«ããã³ã·ã¯ããããã«ããç¬ç«ã«éžæãããåºïŒåãïŒåã§çœ®æãããŠããŠãããè«æ±é ïŒã«èšèŒã®ååç©ã
- 次ã®çŸ€ããéžæãããè«æ±é ïŒã«èšèŒã®ååç©ïŒ
â{ïŒâ[ïŒâ(ïŒâã·ã¯ããããã«ã¢ããâããªããžã³âïŒâã€ã«)âããªãžã³âïŒâã€ã«ã¢ãã]âïŒâã¡ãã«âãã§ãã«}âïŒâ(ïŒâã¡ãã«âããã©ãžã³âïŒâã€ã«)âïŒâããªãã«ãªãã¡ãã«âãã³ãºã¢ããïŒ
â{ïŒâ[ïŒâ(ïŒâã·ã¯ããããã«ã¢ããâããªããžã³âïŒâã€ã«)âããªãžã³âïŒâã€ã«ã¢ãã]âïŒâã¡ãã«âãã§ãã«}âïŒâ[ïŒâ(ïŒâããããã·âãšãã«)âããã©ãžã³âïŒâã€ã«]âïŒâããªãã«ãªãã¡ãã«âãã³ãºã¢ããïŒ
â(ïŒâã¡ãã«âïŒâ{ïŒâ[ïŒâ(ïŒâã¢ã«ããªã³âïŒâã€ã«âãšãã«ã¢ãã)âããªããžã³âïŒâã€ã«]âããªãžã³âïŒâã€ã«ã¢ãã}âãã§ãã«)âïŒâããªãã«ãªãã¡ãã«âãã³ãºã¢ããïŒ
â{ïŒâ[ïŒâ(ïŒâã¢ããâããªããžã³âïŒâã€ã«)âããªãžã³âïŒâã€ã«ã¢ãã]âïŒâã¡ãã«âãã§ãã«}âïŒâããªãã«ãªãã¡ãã«âãã³ãºã¢ããïŒ
â{ïŒâ[ïŒâ(ïŒâã¢ããâããªããžã³âïŒâã€ã«)âããªãžã³âïŒâã€ã«ã¢ãã]âïŒâã¡ãã«âãã§ãã«}âïŒâ(ïŒâã¡ãã«âã€ãããŸãŒã«âïŒâã€ã«)âïŒâããªãã«ãªãã¡ãã«âãã³ãºã¢ããïŒ
â[ïŒâ(ïŒâã·ã¯ããããã«ã¢ããâ[ïŒ.ïŒ']ãããªããžãã«âïŒ'âã€ã«ã¢ãã)âïŒâã¡ãã«âãã§ãã«]âïŒâããªãã«ãªãã¡ãã«âãã³ãºã¢ããïŒ
ïŒâtertâããã«âïŒâã¡ãã«âïŒïŒšâãã©ãŸãŒã«âïŒâã«ã«ãã³é ž{ïŒâã¡ãã«âïŒâ[ïŒâ(ïŒâã¢ã«ããªã³âïŒâã€ã«âãšãã«ã¢ãã)â[ïŒ.ïŒ']ãããªããžãã«âïŒ'âã€ã«ã¢ãã]âãã§ãã«}âã¢ããïŒ
â{ïŒâ[ïŒâ(ïŒâã·ã¯ããããã«ã¢ããâããªããžã³âïŒâã€ã«)âããªãžã³âïŒâã€ã«ã¢ãã]âïŒâã¡ãã«âãã§ãã«}âïŒâ(ïŒâã¡ãã«âã€ãããŸãŒã«âïŒâã€ã«)âïŒâããªãã«ãªãã¡ãã«âãã³ãºã¢ããïŒ
â{ïŒâ[ïŒâ(ïŒâã·ã¯ããããã«ã¢ããâããªããžã³âïŒâã€ã«)âããªãžã³âïŒâã€ã«ã¢ãã]âïŒâã¡ãã«âãã§ãã«}âïŒâ(ïŒâã¡ãã«âãããªãžã³âïŒâã€ã«ãªãã·)âïŒâããªãã«ãªãã¡ãã«âãã³ãºã¢ããïŒ
ïŒâtertâããã«âïŒâã¡ãã«âïŒïŒšâãã©ãŸãŒã«âïŒâã«ã«ãã³é ž{ïŒâ[ïŒâ(ïŒâã·ã¯ããããã«ã¢ããâããªããžã³âïŒâã€ã«)âããªãžã³âïŒâã€ã«ã¢ãã]âïŒâã¡ãã«âãã§ãã«}âã¢ããïŒ
ïŒâtertâããã«âããªãã§ã³âïŒâã«ã«ãã³é ž{ïŒâ[ïŒâ(ïŒâã·ã¯ããããã«ã¢ããâããªããžã³âïŒâã€ã«)âããªãžã³âïŒâã€ã«ã¢ãã]âïŒâã¡ãã«âãã§ãã«}âã¢ããïŒ
ïŒâ[ïŒâ(ïŒâã·ã¯ããããã«ã¢ããâããªããžã³âïŒâã€ã«)âããªãžã³âïŒâã€ã«ã¢ãã]âïŒâã¡ãã«ââ(ïŒâããªãã«ãªãã¡ãã«âãã§ãã«)âãã³ãºã¢ããïŒ
ïŒâ[ïŒâ(ïŒâã·ã¯ããããã«ã¢ããâããªããžã³âïŒâã€ã«)âããªãžã³âïŒâã€ã«ã¢ãã]âïŒâã¡ãã«ââ[ïŒâ(ïŒâã¡ãã«âã€ãããŸãŒã«âïŒâã€ã«)âïŒâããªãã«ãªãã¡ãã«âãã§ãã«]âãã³ãºã¢ããïŒ
â{ïŒâ[ïŒâ(ïŒâã·ã¯ããããã«ã¢ããâããªããžã³âïŒâã€ã«)âããªãžã³âïŒâã€ã«ã¢ãã]âïŒâã¡ãã«âãã§ãã«}âïŒâããªãã«ãªãã¡ãã«âãã³ãºã¢ããïŒ
â{ïŒâ[ïŒâ(ïŒâã·ã¯ããããã«ã¢ããâããªããžã³âïŒâã€ã«)âããªãžã³âïŒâã€ã«ã¢ãã]âïŒâã¡ãã«âãã§ãã«}âïŒâ(ïŒâãšãã«ããã©ãžã³âïŒâã€ã«ã¡ãã«)âïŒâããªãã«ãªãã¡ãã«âãã³ãºã¢ããïŒ
ïŒâã¯ããââ{ïŒâ[ïŒâ(ïŒâã·ã¯ããããã«ã¢ããâããªããžã³âïŒâã€ã«)âããªãžã³âïŒâã€ã«ã¢ãã]âïŒâã¡ãã«âãã§ãã«}âïŒâããªãã«ãªãã¡ãã«âãã³ãºã¢ããïŒ
â(ïŒâã¡ãã«âïŒâ{ïŒâ[ïŒâ(ïŒâã¢ã«ããªã³âïŒâã€ã«âãšãã«ã¢ãã)âããªããžã³âïŒâã€ã«]âããªãžã³âïŒâã€ã«ã¢ãã}âãã§ãã«)âïŒâããªãã«ãªãã¡ãã«âãã³ãºã¢ããïŒ
ïŒâã¯ããââ(ïŒâã¡ãã«âïŒâ{ïŒâ[ïŒâ(ïŒâã¢ã«ããªã³âïŒâã€ã«âãšãã«ã¢ãã)âããªããžã³âïŒâã€ã«]âããªãžã³âïŒâã€ã«ã¢ãã}âãã§ãã«)âïŒâããªãã«ãªãã¡ãã«âãã³ãºã¢ããïŒ
ïŒâ(ïŒâã¡ãã«âã€ãããŸãŒã«âïŒâã€ã«)ââ(ïŒâã¡ãã«âïŒâ{ïŒâ[ïŒâ(ïŒâã¢ã«ããªã³âïŒâã€ã«âãšãã«ã¢ãã)âããªããžã³âïŒâã€ã«]âããªãžã³âïŒâã€ã«ã¢ãã}âãã§ãã«)âïŒâããªãã«ãªãã¡ãã«âãã³ãºã¢ããïŒ
â(ïŒâã¡ãã«âïŒâ{ïŒâ[ïŒâ(ïŒâã¢ã«ããªã³âïŒâã€ã«âãšãã«ã¢ãã)âããªããžã³âïŒâã€ã«]âããªãžã³âïŒâã€ã«ã¢ãã}âãã§ãã«)âïŒâ(ïŒâã¡ãã«âãããªãžã³âïŒâã€ã«ãªãã·)âïŒâããªãã«ãªãã¡ãã«âãã³ãºã¢ããïŒ
ïŒâ(ïŒâãšãã«âããã©ãžã³âïŒâã€ã«)ââ(ïŒâã¡ãã«âïŒâ{ïŒâ[ïŒâ(ïŒâã¢ã«ããªã³âïŒâã€ã«âãšãã«ã¢ãã)âããªããžã³âïŒâã€ã«]âããªãžã³âïŒâã€ã«ã¢ãã}âãã§ãã«)âïŒâããªãã«ãªãã¡ãã«âãã³ãºã¢ããïŒ
ïŒâtertâããã«âïŒâã¡ãã«âïŒïŒšâãã©ãŸãŒã«âïŒâã«ã«ãã³é ž(ïŒâã¡ãã«âïŒâ{ïŒâ[ïŒâ(ïŒâã¢ã«ããªã³âïŒâã€ã«âãšãã«ã¢ãã)âããªããžã³âïŒâã€ã«]âããªãžã³âïŒâã€ã«ã¢ãã}âãã§ãã«)âã¢ããïŒ
ïŒâtertâããã«âïŒâã¡ãã«âïŒïŒšâãã©ãŸãŒã«âïŒâã«ã«ãã³é ž(ïŒâã¡ãã«âïŒâ{ïŒâ[ïŒâ(ïŒâã¢ã«ããªã³âïŒâã€ã«âãšãã«ã¢ãã)âããªããžã³âïŒâã€ã«]âããªãžã³âïŒâã€ã«ã¢ãã}âãã§ãã«)âã¢ããïŒ
ïŒâã¡ãã«âïŒâ{ïŒâ[ïŒâ(ïŒâã¢ã«ããªã³âïŒâã€ã«âãšãã«ã¢ãã)âããªããžã³âïŒâã€ã«]âããªãžã³âïŒâã€ã«ã¢ãã}ââ(ïŒâããªãã«ãªãã¡ãã«âãã§ãã«)âãã³ãºã¢ããïŒ
â(ïŒâã¯ããâïŒâããªãã«ãªãã¡ãã«âãã§ãã«)âïŒâã¡ãã«âïŒâ{ïŒâ[ïŒâ(ïŒâã¢ã«ããªã³âïŒâã€ã«âãšãã«ã¢ãã)âããªããžã³âïŒâã€ã«]âããªãžã³âïŒâã€ã«ã¢ãã}âãã³ãºã¢ããïŒ
ïŒâ[ïŒâ(ïŒâã¢ããâããªããžã³âïŒâã€ã«)âããªãžã³âïŒâã€ã«ã¢ãã]âïŒâã¡ãã«ââ(ïŒâããªãã«ãªãã¡ãã«âãã§ãã«)âãã³ãºã¢ããïŒ
ïŒâ[ïŒâ(ïŒâã¢ããâããªããžã³âïŒâã€ã«)âããªãžã³âïŒâã€ã«ã¢ãã]ââ(ïŒâã¯ããâïŒâããªãã«ãªãã¡ãã«ãã§ãã«)âïŒâã¡ãã«âãã³ãºã¢ããïŒ
â{ïŒâ[ïŒâ(ïŒâã¢ããâããªããžã³âïŒâã€ã«)âããªãžã³âïŒâã€ã«ã¢ãã]âïŒâã¡ãã«âãã§ãã«}âïŒâ(ïŒâã¡ãã«âã€ãããŸãŒã«âïŒâã€ã«)âïŒâããªãã«ãªãã¡ãã«âãã³ãºã¢ããïŒ
â{ïŒâ[ïŒâ(ïŒâã¢ããâããªããžã³âïŒâã€ã«)âããªãžã³âïŒâã€ã«ã¢ãã]âïŒâã¡ãã«âãã§ãã«}âïŒâ(ïŒâãšãã«âããã©ãžã³âïŒâã€ã«)âïŒâããªãã«ãªãã¡ãã«âãã³ãºã¢ããïŒ
â{ïŒâ[ïŒâ(ïŒâã¢ããâããªããžã³âïŒâã€ã«)âããªãžã³âïŒâã€ã«ã¢ãã]âïŒâã¡ãã«âãã§ãã«}âïŒâ(ïŒâã¡ãã«âããã©ãžã³âïŒâã€ã«ã¡ãã«)âïŒâããªãã«ãªãã¡ãã«âãã³ãºã¢ããïŒ
â{ïŒâ[ïŒâ(ïŒâã¢ããâããªããžã³âïŒâã€ã«)âããªãžã³âïŒâã€ã«ã¢ãã]âïŒâã¡ãã«âãã§ãã«}âïŒâ(ïŒâã¡ãã«âãããªãžã³âïŒâã€ã«ãªãã·)âïŒâããªãã«ãªãã¡ãã«âãã³ãºã¢ããïŒ
ïŒâtertâããã«âïŒâã¡ãã«âïŒïŒšâãã©ãŸãŒã«âïŒâã«ã«ãã³é ž{ïŒâ[ïŒâ(ïŒâã¢ããâããªããžã³âïŒâã€ã«)âããªãžã³âïŒâã€ã«ã¢ãã]âïŒâã¡ãã«âãã§ãã«}âã¢ããïŒ
ïŒâtertâããã«âïŒâã¡ãã«âïŒïŒšâãã©ãŸãŒã«âïŒâã«ã«ãã³é ž{ïŒâ[ïŒâ(ïŒâã¢ããâããªããžã³âïŒâã€ã«)âããªãžã³âïŒâã€ã«ã¢ãã]âïŒâã¡ãã«âãã§ãã«}âã¢ããïŒ
ïŒâtertâããã«âããªãã§ã³âïŒâã«ã«ãã³é ž{ïŒâ[ïŒâ(ïŒâã¢ããâããªããžã³âïŒâã€ã«)âããªãžã³âïŒâã€ã«âã¢ãã]âïŒâã¡ãã«âãã§ãã«}âã¢ããïŒ
â{ïŒâ[ïŒâ(ïŒâã¢ããâããªããžã³âïŒâã€ã«)âããªãžã³âïŒâã€ã«ã¢ãã]âïŒâã¡ãã«âãã§ãã«}âïŒâããã©ãžã³âïŒâã€ã«âïŒâããªãã«ãªãã¡ãã«âãã³ãºã¢ããïŒ
â{ïŒâ[ïŒâ(ïŒâã¢ããâããªããžã³âïŒâã€ã«)âããªãžã³âïŒâã€ã«ã¢ãã]âïŒâã¡ãã«âãã§ãã«}âïŒâ(ïŒâã¡ãã«âããã©ãžã³âïŒâã€ã«)âïŒâããªãã«ãªãã¡ãã«âãã³ãºã¢ããïŒ
â{ïŒâ[ïŒâ(ïŒâã¢ããâããªããžã³âïŒâã€ã«)âããªãžã³âïŒâã€ã«ã¢ãã]âïŒâã¡ãã«âãã§ãã«}âïŒâ[ïŒâ(ïŒâããããã·âãšãã«)âããã©ãžã³âïŒâã€ã«]âïŒâããªãã«ãªãã¡ãã«âãã³ãºã¢ããïŒ
ïŒâ[ïŒâ(ïŒâã¢ã»ãã«ã¢ããâããªããžã³âïŒâã€ã«)âããªãžã³âïŒâã€ã«ã¢ãã]ââ[ïŒâ(ïŒâãšãã«âããã©ãžã³âïŒâã€ã«âã¡ãã«)âïŒâããªãã«ãªãã¡ãã«âãã§ãã«]âïŒâã¡ãã«âãã³ãºã¢ããïŒ
â(ïŒâã¡ãã«âïŒâ{ïŒâ[ïŒâ(ïŒâã¢ã«ããªã³âïŒâã€ã«ã¡ãã«âããªãžã³âïŒâã€ã«ã¢ãã)âããªããžã³âïŒâã€ã«]âããªãžã³âïŒâã€ã«ã¢ãã}âãã§ãã«)âïŒâããªãã«ãªãã¡ãã«âãã³ãºã¢ããïŒ
â(ïŒâã¡ãã«âïŒâ{ïŒâ[ïŒâ(ïŒâã¢ã«ããªã³âïŒâã€ã«ã¡ãã«âããªãžã³âïŒâã€ã«ã¢ãã)âããªããžã³âïŒâã€ã«]âããªãžã³âïŒâã€ã«ã¢ãã}âãã§ãã«)âïŒâããªãã«ãªãã¡ãã«âãã³ãºã¢ããïŒ
â(ïŒâ{ïŒâ[ïŒâ(ïŒâãžã¡ãã«ã¢ããã¡ãã«âããªãžã³âïŒâã€ã«ã¢ãã)âããªããžã³âïŒâã€ã«]âããªãžã³âïŒâã€ã«âã¢ãã}âïŒâã¡ãã«âãã§ãã«)âïŒâããªãã«ãªãã¡ãã«âãã³ãºã¢ããïŒ
â(ïŒâ{ïŒâ[ïŒâ(ïŒâãžã¡ãã«ã¢ããã¡ãã«âããªãžã³âïŒâã€ã«ã¢ãã)âããªããžã³âïŒâã€ã«]âããªãžã³âïŒâã€ã«âã¢ãã}âïŒâã¡ãã«âãã§ãã«)âïŒâããªãã«ãªãã¡ãã«âãã³ãºã¢ããïŒ
â[ïŒâ(ïŒâã·ã¯ããããã«ã¢ããâ[ïŒ.ïŒ']ãããªããžãã«âïŒ'âã€ã«ã¢ãã)âïŒâã¡ãã«âãã§ãã«]âïŒâããªãã«ãªãã¡ãã«âãã³ãºã¢ããïŒ
â(ïŒâã¡ãã«âïŒâ{ïŒâ[ïŒâ(ïŒâã¡ãã«âããã©ãžã³âïŒâã€ã«)âãšãã«ã¢ãã]â[ïŒ.ïŒ']ãããªããžãã«âïŒ'âã€ã«âã¢ãã}âãã§ãã«)âïŒâããªãã«ãªãã¡ãã«âãã³ãºã¢ããïŒ
â(ïŒâã¡ãã«âïŒâ{ïŒâ[ïŒâ(ïŒâã¡ãã«âããã©ãžã³âïŒâã€ã«)âãããã«ã¢ãã]â[ïŒ.ïŒ']ãããªããžãã«âïŒ'âã€ã«âã¢ãã}âãã§ãã«)âïŒâããªãã«ãªãã¡ãã«âãã³ãºã¢ããïŒ
â{ïŒâã¡ãã«âïŒâ[ïŒâ(ïŒâã¢ã«ããªã³âïŒâã€ã«âãšãã«ã¢ãã)â[ïŒ.ïŒ']ãããªããžãã«âïŒ'âã€ã«ã¢ãã]âãã§ãã«}âïŒâããªãã«ãªãã¡ãã«âãã³ãºã¢ããïŒ
â[ïŒâ(ïŒâã¢ããâ[ïŒ.ïŒ']ãããªããžãã«âïŒ'âã€ã«ã¢ãã)âïŒâã¡ãã«âãã§ãã«]âïŒâããªãã«ãªãã¡ãã«âãã³ãºã¢ããïŒ
â[ïŒâ(ïŒâã·ã¯ããããã«ã¢ããâ[ïŒ.ïŒ']ãããªããžãã«âïŒ'âã€ã«ã¢ãã)âïŒâã¡ãã«âãã§ãã«]âïŒâ(ïŒâã¡ãã«âããã©ãžã³âïŒâã€ã«)âïŒâããªãã«ãªãã¡ãã«âãã³ãºã¢ããïŒ
â[ïŒâ(ïŒâã·ã¯ããããã«ã¢ããâ[ïŒ.ïŒ']ãããªããžãã«âïŒ'âã€ã«ã¢ãã)âïŒâã¡ãã«âãã§ãã«]âïŒâ(ïŒâãšãã«âããã©ãžã³âïŒâã€ã«)âïŒâããªãã«ãªãã¡ãã«âãã³ãºã¢ããïŒ
â[ïŒâ(ïŒâã·ã¯ããããã«ã¢ããâ[ïŒ.ïŒ']ãããªããžãã«âïŒ'âã€ã«ã¢ãã)âïŒâã¡ãã«âãã§ãã«]âïŒâ[ïŒâ(ïŒâããããã·âãšãã«)âããã©ãžã³âïŒâã€ã«]âïŒâããªãã«ãªãã¡ãã«âãã³ãºã¢ããïŒ
â[ïŒâ(ïŒâã·ã¯ããããã«ã¢ããâ[ïŒ.ïŒ']ãããªããžãã«âïŒ'âã€ã«ã¢ãã)âïŒâã¡ãã«âãã§ãã«]âïŒâ(ïŒâãšãã«âããã©ãžã³âïŒâã€ã«ã¡ãã«)âïŒâããªãã«ãªãã¡ãã«âãã³ãºã¢ããïŒ
ïŒâã¡ãã«âïŒâ[ïŒâ(ïŒâã¢ã«ããªã³âïŒâã€ã«âãšãã«ã¢ãã)â[ïŒ.ïŒ']ãããªããžãã«âïŒ'âã€ã«ã¢ãã]ââ(ïŒâããªãã«ãªãã¡ãã«âãã§ãã«)âãã³ãºã¢ããïŒ
ïŒâã¡ãã«âïŒâ{ïŒâ[ïŒâ(ïŒâã¡ãã«âããã©ãžã³âïŒâã€ã«)âãšãã«ã¢ãã]â[ïŒ.ïŒ']ãããªããžãã«âïŒ'âã€ã«âã¢ãã}ââ(ïŒâããªãã«ãªãã¡ãã«âãã§ãã«)âãã³ãºã¢ããïŒ
ïŒâã¡ãã«âïŒâ[ïŒâ(ïŒâããã©ãžã³âïŒâã€ã«âãšãã«ã¢ãã)â[ïŒ.ïŒ']ãããªããžãã«âïŒ'âã€ã«ã¢ãã]ââ(ïŒâããªãã«ãªãã¡ãã«âãã§ãã«)âãã³ãºã¢ããïŒ
â[ïŒâ(ïŒâããã©ãžãâ[ïŒ.ïŒ']ãããªããžãã«âïŒ'âã€ã«ã¢ãã)âïŒâã¡ãã«âãã§ãã«]âïŒâããªãã«ãªãã¡ãã«âãã³ãºã¢ããïŒ
â[ïŒâ(ïŒâã€ãœãããã«ã¢ããâ[ïŒ.ïŒ']ãããªããžãã«âïŒ'âã€ã«ã¢ãã)âïŒâã¡ãã«âãã§ãã«]âïŒâããªãã«ãªãã¡ãã«âãã³ãºã¢ããïŒ
â[ïŒâã¡ãã«âïŒâ(ïŒâã¡ãã«ã¢ããâ[ïŒ.ïŒ']ãããªããžãã«âïŒ'âã€ã«ã¢ãã)âãã§ãã«]âïŒâããªãã«ãªãã¡ãã«âãã³ãºã¢ããïŒ
â[ïŒâ(ïŒâãšãã«ã¢ããâ[ïŒ.ïŒ']ãããªããžãã«âïŒ'âã€ã«ã¢ãã)âïŒâã¡ãã«âãã§ãã«]âïŒâããªãã«ãªãã¡ãã«âãã³ãºã¢ããïŒ
ïŒâtertâããã«âã€ãœãªããµãŸãŒã«âïŒâã«ã«ãã³é ž{ïŒâã¡ãã«âïŒâ[ïŒâ(ïŒâã¢ã«ããªã³âïŒâã€ã«âãšãã«ã¢ãã)â[ïŒ.ïŒ']ãããªããžãã«âïŒ'âã€ã«ã¢ãã]âãã§ãã«}âã¢ããïŒ
ïŒâtertâããã«âã€ãœãªããµãŸãŒã«âïŒâã«ã«ãã³é ž{ïŒâã¡ãã«âïŒâ[ïŒâ(ïŒâã¢ã«ããªã³âïŒâã€ã«âãšãã«ã¢ãã)â[ïŒ.ïŒ']ãããªããžãã«âïŒ'âã€ã«ã¢ãã]âãã§ãã«}âã¢ããïŒ
ïŒâtertâããã«âïŒâã¡ãã«âïŒïŒšâãã©ãŸãŒã«âïŒâã«ã«ãã³é ž{ïŒâã¡ãã«âïŒâ[ïŒâ(ïŒâã¢ã«ããªã³âïŒâã€ã«âãšãã«ã¢ãã)â[ïŒ.ïŒ']ãããªããžãã«âïŒ'âã€ã«ã¢ãã]âãã§ãã«}âã¢ããïŒ
ïŒâtertâããã«âããªãã§ã³âïŒâã«ã«ãã³é ž{ïŒâã¡ãã«âïŒâ[ïŒâ(ïŒâã¢ã«ããªã³âïŒâã€ã«âãšãã«ã¢ãã)â[ïŒ.ïŒ']ãããªããžãã«âïŒ'âã€ã«ã¢ãã]âãã§ãã«}âã¢ããïŒ
â(ïŒâtertâããã«âãã¢ãŸãŒã«âïŒâã€ã«)âïŒâã¡ãã«âïŒâ[ïŒâ(ïŒâã¢ã«ããªã³âïŒâã€ã«âãšãã«ã¢ãã)â[ïŒ.ïŒ']âãããªããžãã«âïŒ'âã€ã«ã¢ãã]âãã³ãºã¢ããïŒ
â{ïŒâã¡ãã«âïŒâ[ïŒâ(ïŒâãããªãžã³âïŒâã€ã«âãšãã«ã¢ãã)â[ïŒ.ïŒ']ãããªããžãã«âïŒ'âã€ã«ã¢ãã]âãã§ãã«}âïŒâããªãã«ãªãã¡ãã«âãã³ãºã¢ããïŒ
â(ïŒâ{ïŒâ[(ïŒâãšãã«âãããªãžã³âïŒâã€ã«ã¡ãã«)âã¢ãã]â[ïŒ.ïŒ']ãããªããžãã«âïŒ'âã€ã«ã¢ãã}âïŒâã¡ãã«âãã§ãã«)âïŒâããªãã«ãªãã¡ãã«âãã³ãºã¢ããïŒ
â(ïŒâã¡ãã«âïŒâ{ïŒâ[(ãããªãžã³âïŒâã€ã«ã¡ãã«)âã¢ãã]â[ïŒ.ïŒ']ãããªããžãã«âïŒ'âã€ã«ã¢ãã}âãã§ãã«)âïŒâããªãã«ãªãã¡ãã«âãã³ãºã¢ããïŒ
â{ïŒâã¡ãã«âïŒâ[ïŒâ(ãããªãžã³âïŒâã€ã«ã¢ãã)â[ïŒ.ïŒ']ãããªããžãã«âïŒ'âã€ã«ã¢ãã]âãã§ãã«}âïŒâããªãã«ãªãã¡ãã«âãã³ãºã¢ããïŒ
â{ïŒâã¡ãã«âïŒâ[ïŒâ(ïŒâã¡ãã«âãããªãžã³âïŒâã€ã«ã¢ãã)â[ïŒ.ïŒ']ãããªããžãã«âïŒ'âã€ã«ã¢ãã]âãã§ãã«}âïŒâããªãã«ãªãã¡ãã«âãã³ãºã¢ããïŒ
â{ïŒâã¡ãã«âïŒâ[ïŒâ(ïŒâã¡ãã«âããã©ãžã³âïŒâã€ã«ã¢ãã)â[ïŒ.ïŒ']ãããªããžãã«âïŒ'âã€ã«ã¢ãã]âãã§ãã«}âïŒâããªãã«ãªãã¡ãã«âãã³ãºã¢ããïŒ
ïŒâã·ã¯ããããã«âã€ãœãªããµãŸãŒã«âïŒâã«ã«ãã³é ž{ïŒâã¡ãã«âïŒâ[ïŒâ(ïŒâã¢ã«ããªã³âïŒâã€ã«âãšãã«ã¢ãã)â[ïŒ.ïŒ']ãããªããžãã«âïŒ'âã€ã«ã¢ãã]âãã§ãã«}âã¢ããïŒ
ïŒâã·ã¯ããããã«âïŒïŒšâãã©ãŸãŒã«âïŒâã«ã«ãã³é ž{ïŒâã¡ãã«âïŒâ[ïŒâ(ïŒâã¢ã«ããªã³âïŒâã€ã«âãšãã«ã¢ãã)â[ïŒ.ïŒ']ãããªããžãã«âïŒ'âã€ã«ã¢ãã]âãã§ãã«}âã¢ããïŒ
ïŒâ(ïŒâ(ïŒâ(ã¡ãã«ã¢ãã)ããªããžã³âïŒâã€ã«)ããªããžã³âïŒâã€ã«ã¢ãã)ââ(ïŒâã¡ããã·ããªãžã³âïŒâã€ã«)âïŒâã¡ãã«ãã³ãºã¢ããïŒ
ïŒâ(ïŒâ(ïŒâ(ã¡ãã«ã¢ãã)ããªããžã³âïŒâã€ã«)ããªããžã³âïŒâã€ã«ã¢ãã)ââ(ïŒâã¯ããããªãžã³âïŒâã€ã«)âïŒâã¡ãã«ãã³ãºã¢ããïŒ
ïŒâ(ïŒâ(ïŒâ(ã¡ãã«ã¢ãã)ããªããžã³âïŒâã€ã«)ããªããžã³âïŒâã€ã«ã¢ãã)ââ(ïŒâ(ããªãã«ãªãã¡ãã«)âãã¢ãŸãŒã«âïŒâã€ã«)âïŒâã¡ãã«ãã³ãºã¢ããïŒ
ïŒâ(ïŒâ(ïŒâ(ã¡ãã«ã¢ãã)ããªããžã³âïŒâã€ã«)ããªãžã³âïŒâã€ã«ã¢ãã)ââ(ïŒâ(ïŒâ(ãžã¡ãã«ã¢ãã)âããããã·)âïŒâ(ããªãã«ãªãã¡ãã«)ãã§ãã«)âïŒâã¡ãã«ãã³ãºã¢ããïŒ
ïŒâ(ïŒâ(ïŒâ(ã¡ãã«ã¢ãã)ããªããžã³âïŒâã€ã«)ããªãžã³âïŒâã€ã«ã¢ãã)ââ(ïŒâ(â(ïŒâ(ãžã¡ãã«ã¢ãã)âãšãã«)ââã¡ãã«ã¢ãã)âïŒâ(ããªãã«ãªãã¡ãã«)ãã§ãã«)âïŒâã¡ãã«ãã³ãºã¢ããïŒ
ïŒâ(ïŒâ(ïŒâ(ã¡ãã«ã¢ãã)ããªããžã³âïŒâã€ã«)ããªããžã³âïŒâã€ã«ã¢ãã)ââ(ïŒâ(ããªãã«ãªãã¡ãã«)âïŒâ(ã¢ã«ããªãã¡ãã«)ãã§ãã«)âïŒâã¡ãã«ãã³ãºã¢ããïŒ
ïŒâ(ïŒâ(ïŒâ(ã¡ãã«ã¢ãã)ããªããžã³âïŒâã€ã«)ããªããžã³âïŒâã€ã«ã¢ãã)ââ(ïŒâtertâããã«âïŒ,ïŒ,ïŒâãã¢ãžã¢ãŸãŒã«âïŒâã€ã«)âïŒâã¡ãã«ãã³ãºã¢ããïŒ
ïŒâ(ïŒâ(ïŒâ(ã¡ãã«ã¢ãã)ããªããžã³âïŒâã€ã«)ããªããžã³âïŒâã€ã«ã¢ãã)ââ(ïŒâ(ããªãã«ãªãã¡ãã«)âïŒâ(ïŒâãªããœãããªãžã³âïŒâã€ã«)ãã§ãã«)âïŒâã¡ãã«ãã³ãºã¢ããïŒ
ïŒâ(ïŒâ(ïŒâ(ã¡ãã«ã¢ãã)ããªããžã³âïŒâã€ã«)ããªããžã³âïŒâã€ã«ã¢ãã)ââ(ïŒâ(â(ïŒâ(ãžã¡ãã«ã¢ãã)âãšãã«)ââã¡ãã«ã¢ãã)âïŒâ(ããªãã«ãªãã¡ãã«)ãã§ãã«)âïŒâã¡ãã«ãã³ãºã¢ããïŒ
ïŒâ(ïŒâ(ïŒâ(ã¡ãã«ã¢ãã)ããªããžã³âïŒâã€ã«)ããªããžã³âïŒâã€ã«ã¢ãã)ââ(ïŒâãšãã«ããªãžã³âïŒâã€ã«)âïŒâã¡ãã«ãã³ãºã¢ããïŒ
ïŒâ(ïŒâ(ïŒâ(ã¡ãã«ã¢ãã)ããªããžã³âïŒâã€ã«)ããªããžã³âïŒâã€ã«ã¢ãã)ââ(ïŒâtertâããã«âïŒâã¡ãã«âãã¢ãŸãŒã«âïŒâã€ã«)âïŒâã¡ãã«ãã³ãºã¢ããïŒ
ïŒâ(ïŒâ(ïŒâ(ã¡ãã«ã¢ãã)ããªããžã³âïŒâã€ã«)ããªããžã³âïŒâã€ã«ã¢ãã)ââ(ïŒâtertâããã«ãã¢ãŸãŒã«âïŒâã€ã«)âïŒâã¡ãã«ãã³ãºã¢ããïŒ
ïŒâ(ïŒâ(ïŒâ(ã¡ãã«ã¢ãã)ããªããžã³âïŒâã€ã«)ããªããžã³âïŒâã€ã«ã¢ãã)ââ(ïŒâ(ããªãã«ãªãã¡ãã«)âããªãžã³âïŒâã€ã«)âïŒâã¡ãã«ãã³ãºã¢ããïŒ
ïŒâ(ïŒâ(ïŒâ(ã¡ãã«ã¢ãã)ããªããžã³âïŒâã€ã«)ããªããžã³âïŒâã€ã«ã¢ãã)ââ(ïŒâ(ããªãã«ãªãã¡ãã«)âããªãžã³âïŒâã€ã«)âïŒâã¡ãã«ãã³ãºã¢ããïŒ
ïŒâ(ïŒâ(ïŒâ(ã¡ãã«ã¢ãã)ããªããžã³âïŒâã€ã«)ããªããžã³âïŒâã€ã«ã¢ãã)âïŒâã¡ãã«ââ(ããªãžã³âïŒâã€ã«)âãã³ãºã¢ããïŒ
ïŒâ(ïŒâ(ïŒâ(ã¡ãã«ã¢ãã)ããªããžã³âïŒâã€ã«)ããªããžã³âïŒâã€ã«ã¢ãã)ââ(ïŒâ(ããªãã«ãªãã¡ãã«)âïŒâ(ïŒâãªããœã¢ãŒããžã³âïŒâã€ã«)ãã§ãã«)âïŒâã¡ãã«ãã³ãºã¢ããïŒ
ïŒâ(ïŒâ(ïŒâ(ã¡ãã«ã¢ãã)ããªããžã³âïŒâã€ã«)ããªããžã³âïŒâã€ã«ã¢ãã)âïŒâã¡ãã«ââ(ããªãžã³âïŒâã€ã«)âãã³ãºã¢ããïŒ
ïŒâ(ïŒâ(ïŒâ(ã¡ãã«ã¢ãã)ããªããžã³âïŒâã€ã«)ããªããžã³âïŒâã€ã«ã¢ãã)ââ(ïŒâãšãã«âïŒïŒšâãã©ãŸãŒã«âïŒâã€ã«)âïŒâã¡ãã«ãã³ãºã¢ããïŒ
ïŒâ(ïŒâ(ïŒâ(ã¡ãã«ã¢ãã)ããªããžã³âïŒâã€ã«)ããªããžã³âïŒâã€ã«ã¢ãã)ââ(ïŒâ(ããªãã«ãªãã¡ãã«)âïŒâã¢ã«ããªããã§ãã«)âïŒâã¡ãã«ãã³ãºã¢ããïŒ
â(ïŒâ(ïŒâ(ãžã¡ãã«ã¢ãã)ããããã·)âïŒâ(ããªãã«ãªãã¡ãã«)ãã§ãã«)âïŒâ(ïŒâ(ïŒâ(ã¡ãã«ã¢ãã)âããªããžã³âïŒâã€ã«)ããªããžã³âïŒâã€ã«ã¢ãã)âïŒâã¡ãã«ãã³ãºã¢ããïŒ
ïŒâ(ïŒâ(ïŒâ(ã¡ãã«ã¢ãã)ããªããžã³âïŒâã€ã«)ããªããžã³âïŒâã€ã«ã¢ãã)ââ(ïŒâ(ããªãã«ãªãã¡ãã«)âïŒâ(ïŒâãªããœã¢ãŒããžã³âïŒâã€ã«)ãã§ãã«)âïŒâã¡ãã«ãã³ãºã¢ããïŒ
ïŒâ(ïŒâ(ïŒâ(ã¡ãã«ã¢ãã)ããªããžã³âïŒâã€ã«)ããªããžã³âïŒâã€ã«ã¢ãã)ââ(ïŒâ(ããªãã«ãªãã¡ãã«)âïŒâ(ïŒâã¡ãã«ããã©ãžã³âïŒâã€ã«)ãã§ãã«)âïŒâã¡ãã«ãã³ãºã¢ããïŒããã³
ïŒâ(ïŒâ(ïŒâ(ã¡ãã«ã¢ãã)ããªããžã³âïŒâã€ã«)ããªããžã³âïŒâã€ã«ã¢ãã)ââ(ïŒâ(â(ïŒâ(ãžã¡ãã«ã¢ãã)âãããã«)ââã¡ãã«ã¢ãã)âïŒâ(ããªãã«ãªãã¡ãã«)ãã§ãã«)âïŒâã¡ãã«ãã³ãºã¢ããã - è«æ±é ïŒã«èšèŒã®ååç©ã®æ²»ççæå¹éããå»è¬çã«èš±å®¹ãããæ·»å å€ãšçµåããŠå«ãå»è¬çµæç©ã
- ãããŒãŒæŽ»æ§ã®é»å®³ããã®çŸæ£ã®ç çããã³ïŒãŸãã¯çåãé»å®³ãŸãã¯æ¹åã§ããåç©ã®çŸæ£ãåŠçœ®ããæ¹æ³ã§ãã£ãŠããã®åç©ã«æ²»ççæå¹éã®è«æ±é ïŒã«èšèŒã®ååç©ãæäžããããšãå«ãæ¹æ³ã
- ãããŒãŒãïŒïŒ¡ïœïœãïœïœâïœïœãïœïœãïœâãïœâãïœâãããïŒãïŒãïœïœãïŒïœ ïœãαãïŒÎ±ãïœïœ ïŒãïœïœïŒ¢ããã³ïŒ°ïŒïŒïŒ³ïŒïŒ«ããéžæãããè«æ±é ïŒã«èšèŒã®æ¹æ³ã
- ïœïœãïœïœâïœïœãïœïœãïœâãïœâãïœâãããïŒãïŒãïœïœãïŒïœ ïœãαãïŒÎ±ãïœïœ ïŒãïœïœïŒ¢ããã³ïŒ°ïŒïŒïŒ³ïŒïŒ«ã®ãããŒãŒæŽ»æ§ããã®çŸæ£ã®ç çããã³ïŒãŸãã¯çåã«å¯äžããåç©ã®çŸæ£ãåŠçœ®ããããã®è¬å€ã®è£œé ã«ãããè«æ±é ïŒã«èšèŒã®ååç©ã®äœ¿çšã
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US77104506P | 2006-02-06 | 2006-02-06 | |
PCT/US2007/003319 WO2007092531A2 (en) | 2006-02-06 | 2007-02-06 | Compounds and compositions as protein kinase inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2009525978A JP2009525978A (ja) | 2009-07-16 |
JP2009525978A5 true JP2009525978A5 (ja) | 2010-03-25 |
Family
ID=38255301
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008553429A Pending JP2009525978A (ja) | 2006-02-06 | 2007-02-06 | ãããã€ã³ãããŒãŒé»å®³å€ãšããŠã®ååç©ããã³çµæç© |
Country Status (10)
Country | Link |
---|---|
US (1) | US20090069327A1 (ja) |
EP (1) | EP1981870A2 (ja) |
JP (1) | JP2009525978A (ja) |
KR (1) | KR20080092412A (ja) |
CN (1) | CN101421262A (ja) |
AU (1) | AU2007212345A1 (ja) |
BR (1) | BRPI0707666A2 (ja) |
CA (1) | CA2637225A1 (ja) |
RU (1) | RU2008135690A (ja) |
WO (1) | WO2007092531A2 (ja) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200811134A (en) | 2006-07-12 | 2008-03-01 | Irm Llc | Compounds and compositions as protein kinase inhibitors |
US9273077B2 (en) | 2008-05-21 | 2016-03-01 | Ariad Pharmaceuticals, Inc. | Phosphorus derivatives as kinase inhibitors |
LT2300013T (lt) | 2008-05-21 | 2017-12-27 | Ariad Pharmaceuticals, Inc. | Fosforo dariniai kaip kinazių inhibitoriai |
WO2009158432A2 (en) | 2008-06-27 | 2009-12-30 | Amgen Inc. | Ang-2 inhibition to treat multiple sclerosis |
UY32582A (es) * | 2009-04-28 | 2010-11-30 | Amgen Inc | Inhibidores de fosfoinositida 3 cinasa y/u objetivo mamÃfero |
KR101911202B1 (ko) * | 2010-08-07 | 2018-10-23 | ë 늬ìì¹ íìŽë°ìŽì í¬ ë ì€í ìŽíž ì ëë²ìí° ì€ëž ëŽì | ìì° íí©ë¬Œ ë° í-믞ì묌ì 륌 í¬íšíë 구ê°ì© ì¡°ì±ë¬Œ |
US9216981B2 (en) | 2010-12-02 | 2015-12-22 | Medpacto, Inc. | Purinylpyridinylamino-2,4-difluorophenyl sulfonamide derivative, pharmaceutically acceptable salt thereof, preparation method thereof, and pharmaceutical composition with inhibitory activity against Raf kinase, containing same as active ingredient |
CN103501612B (zh) | 2011-05-04 | 2017-03-29 | é¿éäºåŸ·å»è¯è¡ä»œæéå ¬åž | æå¶è¡šç®çé¿å ååäœå¯ŒèŽçççäžç»èå¢æ®çååç© |
CA2833771C (en) * | 2011-06-10 | 2021-08-03 | Merck Patent Gmbh | Compositions and methods for the production of pyrimidine and pyridine compounds with btk inhibitory activity |
US9061028B2 (en) | 2012-02-15 | 2015-06-23 | Natco Pharma Limited | Process for the preparation of Nilotinib |
US20150166591A1 (en) | 2012-05-05 | 2015-06-18 | Ariad Pharmaceuticals, Inc. | Methods and compositions for raf kinase mediated diseases |
US9611283B1 (en) | 2013-04-10 | 2017-04-04 | Ariad Pharmaceuticals, Inc. | Methods for inhibiting cell proliferation in ALK-driven cancers |
WO2017147700A1 (en) | 2016-03-01 | 2017-09-08 | Ontario Institute For Cancer Research (Oicr) | Inhibitors of wdr5 protein-protein binding |
EP3423437A4 (en) | 2016-03-01 | 2019-07-24 | Propellon Therapeutics Inc. | INHIBITORS OF THE LINK BETWEEN THE WDR5 PROTEIN AND ITS LIAISON PARTNERS |
TWI763722B (zh) | 2016-10-14 | 2022-05-11 | çŸåæ䌯士æå èš±ç±³å ¬åž | Tyk2æå¶ååå ¶çšé |
US20220048883A1 (en) * | 2018-09-13 | 2022-02-17 | University Of Southern California | Novel fgfr inhibitors and uses thereof |
AU2020223172A1 (en) * | 2019-02-14 | 2021-10-07 | Bridgene Biosciences, Inc. | FGFR inhibitors for the treatment of cancer |
WO2022206939A1 (zh) * | 2021-04-03 | 2022-10-06 | æµ·åèè»çç©å»è¯ç§ææéå ¬åž | äœäžºfgfræå¶åçæç¯ååç©åå ¶åºçš |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7189729B2 (en) * | 2003-09-30 | 2007-03-13 | Irm Llc | Methods and compositions as protein kinase inhibitors |
MXPA06012613A (es) * | 2004-05-07 | 2007-01-31 | Amgen Inc | Derivados heterociclicos nitrogenados como moduladores de proteina cinasa y uso para el tratamiento de angiogenesis y cancer. |
-
2007
- 2007-02-06 KR KR1020087019186A patent/KR20080092412A/ko not_active Application Discontinuation
- 2007-02-06 CA CA002637225A patent/CA2637225A1/en not_active Abandoned
- 2007-02-06 BR BRPI0707666-5A patent/BRPI0707666A2/pt not_active IP Right Cessation
- 2007-02-06 CN CNA2007800046499A patent/CN101421262A/zh active Pending
- 2007-02-06 AU AU2007212345A patent/AU2007212345A1/en not_active Abandoned
- 2007-02-06 RU RU2008135690/04A patent/RU2008135690A/ru not_active Application Discontinuation
- 2007-02-06 EP EP07717222A patent/EP1981870A2/en not_active Withdrawn
- 2007-02-06 JP JP2008553429A patent/JP2009525978A/ja active Pending
- 2007-02-06 US US12/162,313 patent/US20090069327A1/en not_active Abandoned
- 2007-02-06 WO PCT/US2007/003319 patent/WO2007092531A2/en active Application Filing
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2009525978A5 (ja) | ||
RU2401265C2 (ru) | Ð¡ÐŸÐµÐŽÐžÐœÐµÐœÐžÑ Ðž кПЌпПзОÑОО в каÑеÑÑве ОМгОбОÑПÑПв пÑПÑÐµÐžÐœÐºÐžÐœÐ°Ð·Ñ | |
RU2008135690A (ru) | Ð¡ÐŸÐµÐŽÐžÐœÐµÐœÐžÑ Ðž кПЌпПзОÑОО в каÑеÑÑве ОМгОбОÑПÑПв пÑПÑÐµÐžÐœÐºÐžÐœÐ°Ð·Ñ | |
JP2009541268A5 (ja) | ||
CA2663366A1 (en) | Compounds and compositions as protein kinase inhibitors | |
ES2512727T3 (es) | Nuevos compuestos | |
RU2606497C2 (ru) | ТОазПлОлÑеМОлбеМзПлÑÑлÑÑПМаЌОЎПпÑПОзвПЎМÑе в каÑеÑÑве ОМгОбОÑПÑПв кОМаз | |
JP2020503299A5 (ja) | ||
JP2014511869A5 (ja) | ||
RU2018138047A (ru) | ÐеÑеÑПÑОклОÑеÑкОе веÑеÑÑва - агПМОÑÑÑ gpr119 | |
JP2014525444A5 (ja) | ||
RU2009101911A (ru) | ÐÑПОзвПЎМÑе пОÑОЎОМа О пОÑазОМа в каÑеÑÑве ОМгОбОÑПÑПв mnk-ÐºÐžÐœÐ°Ð·Ñ | |
JP2012510989A5 (ja) | ||
JP2010510319A5 (ja) | ||
RU2007132262A (ru) | Ð¡ÐŸÐµÐŽÐžÐœÐµÐœÐžÑ Ðž кПЌпПзОÑОО в каÑеÑÑве ОМгОбОÑПÑПв пÑПÑеОМкОМаз | |
JP2009513575A5 (ja) | ||
RU2009125916A (ru) | СПеЎОМеМОÑ-ОМгОбОÑПÑÑ ÑПÑÑПОМПзОÑОЎ 3-ÐºÐžÐœÐ°Ð·Ñ Ðž ÑпПÑÐŸÐ±Ñ Ð¿ÑÐžÐŒÐµÐœÐµÐœÐžÑ | |
JP2008513514A5 (ja) | ||
JP2007523142A5 (ja) | ||
RU2008103143A (ru) | Ð¡ÐŸÐµÐŽÐžÐœÐµÐœÐžÑ Ðž кПЌпПзОÑОО в каÑеÑÑве ОМгОбОÑПÑПв пÑПÑеОМÑОÑÐŸÐ·ÐžÐœÐºÐžÐœÐ°Ð·Ñ | |
JP2009526072A5 (ja) | ||
JP2011515462A5 (ja) | ||
JP2013507449A5 (ja) | ||
RU2013145299A (ru) | ТОазПлПпОÑÐžÐŒÐžÐŽÐžÐœÑ | |
PT1533304E (pt) | Derivado de amida |